Document:

EX-10.3

EXHIBIT 10.3

INVESTMENT AGREEMENT

BY AND BETWEEN

CIFC CORP.

AND

GE CAPITAL EQUITY INVESTMENTS, INC.

Dated as of September 24, 2012

1

TABLE OF CONTENTS

	 	 	 	 	 	 	 	 	 
	ARTICLE I GENERAL	 	 	1	 
	 	 	 	 	Section 1.1 Effective Date
	 	 	1	 
	 	 	 	 	Section 1.2 Definitions
	 	 	2	 
	 	 	 	 	Section 1.3 Construction
	 	 	7	 
	 	 	 	 	Section 1.4 Disclaimer of “Group” Status
	 	 	7	 
	ARTICLE II REPRESENTATIONS AND WARRANTIES	 	 	7	 
	 	 	 	 	Section 2.1 Representations and Warranties of the Company
	 	 	7	 
	 	 	 	 	Section 2.2 Representations and Warranties of the Investor
	 	 	8	 
	ARTICLE III COVENANTS	 	 	9	 
	 	 	 	 	Section 3.1 Reserved Matters
	 	 	9	 
	 	 	 	 	Section 3.2 Notices and Access to Information; Cooperation
	 	 	9	 
	 	 	 	 	Section 3.3 Board of Directors
	 	 	10	 
	 	 	 	 	Section 3.4 Confidentiality
	 	 	12	 
	 	 	 	 	Section 3.5 Purchase of Voting Shares
	 	 	12	 
	ARTICLE IV PREEMPTIVE RIGHTS AND TRANSFER PROVISIONS	 	 	12	 
	 	 	 	 	Section 4.1 Preemptive Rights
	 	 	12	 
	 	 	 	 	Section 4.2 Voting Rights
	 	 	13	 
	 	 	 	 	Section 4.3 Tag-Along Rights
	 	 	13	 
	 	 	 	 	Section 4.4 Additional Provisions Related to Tag Transfers
	 	 	15	 
	 	 	 	 	Section 4.5 Transfer of Investor Shares
	 	 	16	 
	ARTICLE V MISCELLANEOUS	 	 	16	 
	 	 	 	 	Section 5.1 Termination of Agreement
	 	 	16	 
	 	 	 	 	Section 5.2 Dispute Resolution
	 	 	17	 
	 	 	 	 	Section 5.3 Expenses
	 	 	17	 
	 	 	 	 	Section 5.4 Notices
	 	 	17	 
	 	 	 	 	Section 5.5 Governing Law
	 	 	18	 
	 	 	 	 	Section 5.6 Submission to Jurisdiction
	 	 	18	 
	 	 	 	 	Section 5.7 Specific Performance
	 	 	19	 
	 	 	 	 	Section 5.8 Waiver of Jury Trial
	 	 	19	 
	 	 	 	 	Section 5.9 Binding Effect; Persons Benefiting; Assignment
	 	 	19	 
	 	 	 	 	Section 5.10 Counterparts
	 	 	19	 
	 	 	 	 	Section 5.11 Entire Agreement
	 	 	19	 
	 	 	 	 	Section 5.12 Severability
	 	 	19	 
	 	 	 	 	Section 5.13 Amendments and Waivers
	 	 	19	 
	 	 	 	 	Section 5.14 Delays or Omissions
	 	 	20	 
	 	 	 	 	Section 5.15 Mutual Drafting; Interpretation
	 	 	20	 

2

INVESTMENT AGREEMENT

THIS INVESTMENT AGREEMENT, dated as of September 24, 2012 (this “Agreement”), is by
and between CIFC Corp., a Delaware corporation (the “Company”), and GE Capital Equity
Investments, Inc., a Delaware corporation (the “Investor,” and together with the Company,
the “Parties,” and each, a “Party”).

WHEREAS, the Investor and GE Capital Debt Advisors LLC, a Delaware limited liability company
(“GECDA”), are each wholly-owned indirect subsidiaries of General Electric Capital
Corporation, a Delaware corporation (“GECC”);

WHEREAS, the Company, GECDA and GECC entered into that certain Asset Purchase Agreement dated
as of July 30, 2012 (as the same may hereafter be amended, modified, supplemented or restated from
time to time, the “Purchase Agreement”), which provides for, among other things, the
transfer to the Investor of certain shares of common stock of the Company, par value $0.001 per
share (the “Common Stock”), and the Investor Warrant (as defined below) in consideration
for (a) GECDA’s assignment to the Company (or an Affiliate (as defined below) of the Company) of
its rights and obligations under the collateral management agreements relating to the
collateralized loan obligations referred to as Navigator CDO 2003, Ltd., Navigator CDO 2004, Ltd.,
Navigator CDO 2005, Ltd. and Navigator CDO 2006, Ltd., and (b) actions to be taken by GECC and its
Affiliates (as defined below) as described in the Purchase Agreement;

WHEREAS, immediately following the consummation of the transactions contemplated by the
Purchase Agreement (the “Closing”), the Investor shall own (a) 1,000,000 shares of Common
Stock, representing approximately 4.81% of the issued and outstanding shares of Common Stock as of
the date hereof, and (b) a warrant (the “Investor Warrant”) to purchase up to 2,000,000
shares of Common Stock or (if exercised by the Initial Holder (as defined in the Investor Warrant))
Preferred Stock that will be mandatorily exchanged for Common Stock in the case of certain
transfers (the shares issuable upon the exercise of the Investor Warrant, and any other securities
issued in respect thereof or into which such shares or other securities shall be converted or
exchanged in connection with stock splits, reverse stock splits, stock dividends or distributions,
combinations or any other recapitalizations after the date of this Agreement, the “Warrant
Shares”), which Investor Warrant shall be exercisable at any time in whole or in part prior to
the Expiration Date (as defined in the Investor Warrant);

WHEREAS, the Investor has the registration rights with respect to the Investor Shares (as
defined below) and the Warrant Shares that are Common Stock as provided in the Second Amended and
Restated Registration Rights Agreement by and among the Company, the Investor, DFR Holdings (as
defined below), and CIFC Parent (as defined below), of even date herewith (the “Registration
Rights Agreement”);

WHEREAS, the execution and delivery of this Agreement is a condition to the obligations of the
Company and GECC (and their respective Affiliates, as applicable) to consummate the transactions
contemplated by the Purchase Agreement; and

WHEREAS, the Company and the Investor desire to establish certain terms and conditions
concerning the relationship of the Investor with, and its investments in, the Company from and
after the Closing.

NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and
agreements set forth herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Investor agree as follows:

ARTICLE I

GENERAL

Section 1.1 Effective Date. This Agreement shall be delivered at, and shall be
effective as of, the Closing.

Section 1.2 Definitions. As used in this Agreement, the following terms shall have
the meanings indicated below:

“Action” means any judicial, legislative, administrative or arbitral actions, suits,
investigations, audits, claims or other proceedings by or before a Governmental Authority.

“Affiliate” means, with respect to any Person, any other Person, directly or
indirectly through one or more intermediaries, controlling, controlled by or under common control
with such Person; provided, that for purposes of this Agreement, (a) the Company and its
Subsidiaries, on the one hand, shall not be deemed to be Affiliates of any Investor Holder, on the
other hand, and (b) the Major Stockholders, on the one hand, shall not be deemed to be Affiliates
of any Investor Holder or the Company, on the other hand. The term “control” (including,
with correlative meaning, the terms “controlled by” and “under common control
with”), as applied to any Person, means the possession, directly or indirectly, of the power to
direct or cause the direction of the management and policies of such Person, whether through the
ownership of voting or other securities, by contract or otherwise.

“Agreement” has the meaning assigned to such term in the preamble.

“Beneficial Ownership” by a Person of any securities includes ownership by any Person
who, directly or indirectly, through any contract, arrangement, understanding, relationship or
otherwise, has or shares: (i) voting power which includes the power to vote, or to direct the
voting of, such security; and/or (ii) investment power which includes the power to dispose, or to
direct the disposition, of such security; and shall otherwise be interpreted in accordance with the
term “beneficial ownership” as defined in Rule 13d-3 adopted by the SEC under the Exchange Act.
For purposes of this Agreement, (x) a Person shall be deemed to Beneficially Own any securities
Beneficially Owned by its Affiliates or any “group” (as contemplated by Exchange Act Rule 13d-5(b))
of which such Person or any such Affiliate is or becomes a member; provided, that,
notwithstanding the foregoing, no Stockholder shall be deemed to Beneficially Own the Shares
Beneficially Owned by any other Stockholder solely due to the fact that the Stockholders constitute
a group (as contemplated by Exchange Act Rule 13d-5(b)), (y) for the avoidance of doubt, the
Investor shall not be deemed to Beneficially Own the Warrant Shares prior to any exercise of the
Investor Warrant by the Initial Holder, and (z) for the avoidance of doubt, the DFR Holdings
Holders shall be deemed to Beneficially Own the Conversion Shares and neither the Investor nor the
CIFC Holders shall be deemed to Beneficially Own the Conversion Shares. The term “Beneficially
Own” shall have a correlative meaning.

“BHC Act” means the Bank Holding Company Act of 1956, as amended, and the rules and
regulations promulgated thereunder, as in effect from time to time, and any other applicable
Federal banking law, regulation or policy.

“Board” means, as of any date, the Board of Directors of the Company in office on that
date.

“Business Day” means a day other than Saturday, Sunday or any other day on which banks
located in New York, New York are authorized or obligated by Law to close.

“CIFC Holders” means, collectively, CIFC Parent and any Person that is both a
Stockholder and an Affiliate of CIFC Parent and any successors thereto.

“CIFC Parent” means CIFC Parent Holdings LLC, a Delaware limited liability company.

“Closing” has the meaning assigned in the recitals.

“Common Stock” has the meaning assigned to such term in the recitals.

“Company” has the meaning assigned to such term in the preamble.

“Confidential Information” has the meaning assigned to such term in Section
3.4(a).

“Confidentiality Affiliates” has the meaning assigned to such term in Section
3.4(a).

“Consents” means all consents, notices, authorizations, novations, Orders, waivers,
approvals, licenses, accreditations, certificates, declarations, filings or expiration of waiting
periods, non-objection or confirmation by a rating agency that an action or event will not result
in the reduction or withdrawal of a rating.

“Constituent Documents” means, with respect to any Person that is a corporation, its
articles or certificate of incorporation (for the avoidance of doubt, including any certificates of
designation with respect to capital stock of such Person), corporate charter or memorandum and
articles of association, as the case may be, and bylaws, with respect to any Person that is a
partnership, its certificate of partnership and partnership agreement, with respect to any Person
that is a limited liability company, its certificate of formation and limited liability company or
operating agreement, with respect to any Person that is a trust or other entity, its declaration or
agreement of trust or other constituent document, and with respect to any other Person, its
comparable organizational documents, in each case, as amended or restated.

“Contract” means any written or oral contract, agreement, lease, license, indenture,
note, bond, mortgage, loan, instrument, conditional sale contract, guarantee commitment or other
arrangement, understanding, undertaking or obligation.

“Conversion Shares” means the shares of Common Stock into which the Convertible Notes
can be converted.

“Convertible Notes” means those certain Senior Subordinated Convertible Notes
Beneficially Owned by DFR Holdings in the original principal amount of $25,000,000 and due December
9, 2017, which are convertible into shares of Common Stock.

“Corporate Governance Guidelines” means the Corporate Governance Guidelines of the
Company, as amended and restated as of September 15, 2011.

“Cure Period” has the meaning assigned to such term in Section 3.3(a)(v).

“Cure Purchase” has the meaning assigned to such term in Section 3.3(a)(v).

“Denominator Shares” has the meaning assigned to such term in Section
3.3(a)(iv).

“DFR Holdings” means DFR Holdings LLC, a Delaware limited liability company.

“DFR Holdings Holders” means, collectively, DFR Holdings and any Person that is both a
Stockholder and an Affiliate of DFR Holdings and any successors thereto.

“DGCL” means the Delaware General Corporation Law, as amended.

“Dilution Notice” has the meaning assigned to such term in Section 3.3(a)(v).

“Director” means any member of the Board.

“Dispute” has the meaning assigned to such term in Section 5.2(a).

“Equity Interest” means any type of equity ownership in an entity, including
partnership interests in a general partnership or limited partnership, membership interests in a
limited liability company, stock or similar security (and any option, warrant, right or security,
including debt securities, convertible, exchangeable or exercisable thereto or therefor) in a
corporation or the comparable instruments for any other entity or any other interest entitling the
holder thereof to participate in the profits of such entity, the proceeds or the disposition of
such entity or any portion thereof or to vote for the governing body of such entity.

“Escalation Notice” has the meaning assigned to such term in Section 5.2(b).

“Excess Shares” has the meaning assigned to such term in Section 4.2.

“Exchange Act” means the Securities Exchange Act of 1934, and the rules and
regulations promulgated thereunder.

“GECC” has the meaning assigned to such term in the recitals.

“GECDA” has the meaning assigned to such term in the recitals.

“Governmental Approvals” means all Consents of a Governmental Authority required in
connection with the transactions contemplated hereby.

“Governmental Authority” means any foreign, federal, state or local governmental,
judicial, legislative, regulatory or administrative agency, commission or authority, and any court,
tribunal or arbitrator(s) of competent jurisdiction, including Self-Regulatory Organizations.

“Independent Director” has the meaning assigned to such term in the Major Stockholders
Agreement.

“Investor” has the meaning assigned to such term in the preamble.

“Investor Holder” means the Investor and any Person that is both a Stockholder and
either GECC or an Affiliate of GECC.

“Investor Shares” means, as of the applicable measurement date, the sum of the shares
of Common Stock and Other Capital Stock Beneficially Owned by the Investor Holders and any shares
of Common Stock or other securities issued in respect thereof or into which such shares of Common
Stock or other securities shall be converted in connection with stock splits, reverse stock splits,
stock dividends or distributions, combinations or any similar recapitalizations after the date of
this Agreement.

“Investor Warrant” has the meaning assigned to such term in the recitals.

“Law” means any statute, code, Order, law, ordinance, rule, regulation or other
requirement of any Governmental Authority (including, for the sake of clarity, common law).

“Lien” means any lien, pledge, encumbrance, mortgage, deed of trust, security
interest, equity, claim, lease, license, charge, option, adverse right, right of first or last
negotiation, offer or refusal, easement or transfer restriction of any kind or nature whatsoever,
whether arising by agreement, operation of Law or otherwise.

“Major Stockholder” means the DFR Holdings Holders and the CIFC Holders (each a
“Major Stockholder” and together, the “Major Stockholders”).

“Major Stockholders Agreement” means that certain Second Amended and Restated
Stockholders Agreement by and among the Company, DFR Holdings and CIFC Parent, dated as of
September 24, 2012, as amended, supplemented or otherwise modified from time to time.

“NASDAQ” means the NASDAQ Stock Market LLC.

“New Shares” means any Equity Interests of the Company or any of its Subsidiaries,
whether authorized or not by the Board or any committee of the Board, and rights, options, or
warrants to purchase any Equity Interest, and securities of any type whatsoever that are, or may
become, convertible into any Equity Interest; provided, however, that the term “New
Shares” shall not include: (i) securities issued to employees, consultants, officers and directors
of the Company, pursuant to any arrangement approved by the Board or the Board’s compensation
committee; (ii) securities issued as consideration in the acquisition of another business or assets
of another Person by the Company by merger or purchase of the assets or shares, reorganization or
otherwise; (iii) securities issued pursuant to any rights or agreements, including, without
limitation, convertible securities, options and warrants, provided that either (x) the
Company shall have complied with Section 4.1 with respect to the initial sale or grant by
the Company of such rights or agreements or (y) such rights or agreements existed prior to the
Closing (it being understood that any modification or amendment to any such pre-existing right or
agreement subsequent to the Closing with the effect of increasing the percentage of the Company’s
fully-diluted securities underlying such rights agreement shall not be included in this clause
(iii)); (iv) securities issued in connection with any stock split, stock dividend,
recapitalization, reclassification or similar event by the Company; (v) Conversion Shares issued
upon conversion of any portion of the then outstanding Convertible Notes; (vi) warrants issued to
the lender in a bona fide debt financing; (vii) securities registered under the Securities Act that
are issued in an underwritten public offering; (viii) any right, option, or warrant to acquire any
security convertible into the securities excluded from the definition of New Shares pursuant to
clauses (i) through (vii) above; (ix) any issuance by a Subsidiary of the Company to the Company or
a wholly-owned Subsidiary of the Company; or (x) Warrant Shares issued upon exercise of any portion
of the Investor Warrant.

“New Shares Notice” has the meaning assigned to such term in Section 4.1(b).

“New York Court” has the meaning assigned to such term in Section 5.6.

“Nominating Committee” has the meaning assigned to such term in the Major Stockholders
Agreement.

“Notices” has the meaning assigned to such term in Section 5.4.

“Numerator Shares” has the meaning assigned to such term in Section
3.3(a)(iv).

“Observer” has the meaning assigned to such term in Section 3.3(b).

“Order” means any judgment, order, injunction, stipulation, decree, writ, doctrine,
ruling, assessment or arbitration award or similar order of any Governmental Authority.

“Other Capital Stock” means shares of any class of capital stock of the Company (other
than the Common Stock) that are entitled to vote in the election of Directors.

“Party” and “Parties” have the meaning assigned to such term in the preamble.

“Person” means any individual, corporation, partnership, limited liability company,
limited liability partnership, firm, joint venture, association, joint-stock company, trust,
unincorporated organization, Governmental Authority or other entity.

“Preemptive Right” has the meaning assigned to such term in Section 4.1(a).

“Preferred Stock” has the meaning assigned to such term in the Investor Warrant.

“Pro Rata Portion” has the meaning assigned to such term in Section 4.1(a).

“Purchase Agreement” has the meaning assigned to such term in the recitals.

“Registration Rights Agreement” has the meaning assigned to such term in the recitals.

“Reporting Obligations” has the meaning assigned to such term in Section
3.2(b).

“Representatives” of a Person means the directors, trustees, officers, managers,
employees and agents of such Person.

“Rule 144” means Rule 144 under the Securities Act.

“SEC” means the United States Securities and Exchange Commission or any successor
entity thereto.

“Securities Act” means the Securities Act of 1933, and the rules and regulations
promulgated thereunder.

“Self-Regulatory Organization” means each national securities exchange in the United
States of America or other commission, board, agency or body that is charged with the supervision
or regulation of brokers, dealers, securities underwriting or trading, stock exchanges, commodities
exchanges, insurance companies or agents, investment companies or investment advisers, or to the
jurisdiction of which any Party or any of their respective Subsidiaries is otherwise subject.

“Shares” means, collectively (but without duplication), (a) shares of Common Stock,
(b) shares of Preferred Stock, or (c) shares of other classes or series of capital stock of the
Issuer that may exist from time to time.

“Subsidiary” means, with respect to any Person, a corporation or other Person of which
more than fifty percent (50%) of the voting power of the outstanding voting Equity Interests or
more than fifty percent (50%) of the outstanding economic Equity Interest is held, directly or
indirectly, by such Person.

“Stockholders” means the holders of Shares from time to time and “Stockholder”
means any one of them.

“Tag-Along Notice Period” has the meaning assigned to such term in Section
4.3(c).

“Tag-Along Offer” has the meaning assigned to such term in Section 4.3(a).

“Tag-Along Percentage” means with respect to any Tag Transfer the fraction, expressed
as a percentage, determined as of immediately prior to such Tag Transfer by dividing (a) the number
of Shares held by the Investor Holders plus the number of Warrant Shares issuable to the Investor
Holders at such time upon the exercise of the Warrant, by (b) the sum of (i) the Shares held by the
DFR Holdings Holders plus the Conversion Shares issuable to the DRF Holdings Holders, if a DFR
Holdings Holder is a Tag-Along Seller, (ii) the Shares held by the CIFC Holders, if a CIFC Holder
is a Tag-Along Seller and (iii) the Shares held by the Investor Holders plus the number of Warrant
Shares issuable at such time upon the exercise of the Warrant.

“Tag-Along Right” has the meaning assigned to such term in Section 4.3(c).

“Tag-Along Seller” has the meaning assigned to such term in Section 4.3(a).

“Tag Exercise Notice” has the meaning assigned to such term in Section 4.3(c).

“Tag Shares” has the meaning assigned to such term in Section 4.3(c).

“Tag Transfer” has the meaning assigned to such term in Section 4.3(a).

“Tag Transfer Notice” has the meaning assigned to such term in Section 4.3(a).

“Tagging Investors” has the meaning assigned to such term in Section 4.3(c).

“Third Party” means any Person other than the Company, its Subsidiaries, the Investor
and each of such Person’s respective members, directors, officers and Affiliates.

“Third Party Consents” means all required consents from, waivers by, or notices to,
any Person (other than a Governmental Authority) to any Contract to which any of the Parties hereto
is a party or by which any of their respective assets or properties are bound.

“Total Shares” has the meaning assigned to such term in Section 4.1(a).

“Total Investor Shares” has the meaning assigned to such term in Section 4.1(a).

“Threshold Percentage” has the meaning assigned to such term in Section
3.3(a)(iv).

“Trading Day” means any day on which the Common Stock is traded on NASDAQ, or, if
NASDAQ is not the principal trading market for the Common Stock, then on the principal securities
exchange or securities market on which the Common Stock is then traded.

“Transfer” means the transfer of ownership by sale, exchange, assignment, pledge,
encumbrance, lien, gift, donation, grant or other conveyance of any kind, whether voluntary or
involuntary, including conveyances by operation of Law or legal process (and hereby expressly
includes, with respect to an Investor Holder, any voluntary or involuntary appointment of a
receiver, trustee, liquidator, custodian or other similar official for such Investor Holder or all
or any part of such Investor Holder’s property under any bankruptcy Law). For the avoidance of
doubt, the Parties hereto acknowledge and agree that any Transfer of the Equity Interests of the
Investor, either Major Stockholder or any of their respective Affiliates that controls such Person
will be deemed a Transfer of the Shares held by such Person under this Agreement if, following such
Transfer such Person is no longer controlled, directly or indirectly, by other Person or Persons
that control, directly or indirectly, such Person on the date hereof or by an Affiliate or
Affiliates thereof.

“Voting Restriction” has the meaning assigned to such term in Section 4.2.

“Voting Shares” means any outstanding Shares, including the Common Stock, that, as of
the applicable determination date, are entitled to vote on matters submitted to a vote at a meeting
of Stockholders.

“Warrant Shares” has the meaning assigned to such term in the recitals.

Section 1.3 Construction. Unless the context of this Agreement clearly requires
otherwise: (i) references to the plural include the singular and vice versa; (ii) references to one
gender include all genders; (iii) whenever the words “include,” “includes” or “including” are used
in this Agreement they will be deemed to be followed by the phrase “without limitation;” (iv) the
words “hereof,” “herein,” “hereby,” “hereunder” and similar terms in this Agreement refer to this
Agreement as a whole and not to any particular provision of this Agreement; (v) when a reference is
made in this Agreement to a Section, Schedule, Exhibit or Annex, such reference shall be to a
Section, Schedule, Exhibit or Annex of this Agreement unless otherwise indicated; (vi) all
references in this Agreement to “$” are intended to refer to U.S. dollars; (vii) unless otherwise
specifically provided for herein, the term “or” shall not be deemed to be exclusive; and (viii) any
reference to a Law shall include any amendment thereof or any successor thereto and any rules and
regulations promulgated thereunder, as in effect from time to time. The table of contents and
headings contained in this Agreement are for reference purposes only and shall not affect in any
way the meaning or interpretation of this Agreement.

Section 1.4 Disclaimer of “Group” Status. The Investor hereby expressly disclaims
Beneficial Ownership of any Equity Interests in the Company held by any Major Stockholder. This
Agreement shall not constitute a written or oral agreement by the Investor or any Affiliate of the
Investor to act together with any Major Stockholder for the purpose of acquiring, holding, voting
or disposing of any Equity Interests in the Company. 

ARTICLE II

REPRESENTATIONS AND WARRANTIES

Section 2.1 Representations and Warranties of the Company. The Company represents and
warrants to the Investor as of the date hereof that:

(a) The Company is duly incorporated, validly existing and in good standing under the Laws of
the State of Delaware with all requisite power and authority required to conduct its business as
presently conducted.

(b) The Company has all requisite corporate power and authority to execute and deliver this
Agreement and to perform its obligations hereunder. The execution and delivery by the Company of
this Agreement and the performance by the Company of its obligations hereunder have been duly
authorized by all requisite corporate action of the Company. No other action on the part of the
Company is necessary to authorize the execution, delivery and performance by the Company of this
Agreement.

(c) This Agreement has been duly executed and delivered by the Company and, assuming this
Agreement has been duly authorized, executed and delivered by the Investor, constitutes the legal,
valid and binding obligation of the Company, enforceable against the Company in accordance with its
terms, except to the extent that the enforceability thereof may be limited by: (i) applicable
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar Laws from time
to time in effect affecting generally the enforcement of creditors’ rights and remedies and
(ii) general principles of equity, regardless of whether enforcement is sought in equity or at Law.

(d) The execution and delivery of this Agreement by the Company and the performance by the
Company of its obligations under this Agreement: (i) does not violate any provision of the
Constituent Documents of the Company; and (ii)(A) does not conflict with or violate any Law
applicable to the Company or any part of the properties or assets of the Company, (B) except as set
forth on Schedule 2.1(d), does not require the Consent of any Person under, violate, result
in the termination or acceleration of or of any right under, give rise to or modify any right or
obligation under (whether or not in combination with any other event or circumstance), or conflict
with, breach or constitute a default under (in each case with or without notice, the passage of
time or both), any Contract to which the Company is a party or by which any of its properties or
assets is bound, including the Majority Stockholders Agreement, (C) does not result in the creation
or imposition of any Lien on any part of the properties or assets of the Company, (D) does not
violate any Order binding on the Company or any part of its properties or assets, and (E) does not
otherwise require any Governmental Approvals or any Third Party Consents.

Section 2.2 Representations and Warranties of the Investor. The Investor represents
and warrants to the Company that as of the date hereof:

(a) The Investor is duly formed, validly existing and in good standing under the Laws of
Delaware with all requisite power and authority required to conduct its business as presently
conducted.

(b) The Investor has all requisite corporate power and authority to execute and deliver this
Agreement and to perform its obligations hereunder. The execution and delivery by the Investor of
this Agreement and the performance by the Investor of its obligations hereunder have been duly
authorized by all requisite corporate action of the Investor. No other action on the part of the
Investor or its stockholders is necessary to authorize the execution, delivery and performance by
the Investor of this Agreement.

(c) This Agreement has been duly executed and delivered by the Investor and, assuming this
Agreement has been duly authorized, executed and delivered by the Company, constitutes the legal,
valid and binding obligation of the Investor, enforceable against the Investor in accordance with
its terms, except to the extent that the enforceability thereof may be limited by: (i) applicable
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar Laws from time
to time in effect affecting generally the enforcement of creditors’ rights and remedies; and
(ii) general principles of equity regardless of whether enforcement is sought in equity or at Law.

(d) The execution and delivery of this Agreement by the Investor and the performance by the
Investor of its obligations under this Agreement: (i) does not violate any provision of the
Constituent Documents of the Investor; and (ii)(A) does not conflict with or violate any Law
applicable to the Investor or any part of the properties or assets of the Investor, (B) does not
require the Consent of any Person under, violate, result in the termination or acceleration of or
of any right under, give rise to or modify any right or obligation under (whether or not in
combination with any other event or circumstance), or conflict with, breach or constitute a default
under (in each case with or without notice, the passage of time or both), any Contract to which the
Investor is a party or by which any of its properties or assets is bound, (C) does not result in
the creation or imposition of any Lien on any part of the properties or assets of the Investor,
(D) does not violate any Order binding on the Investor or any part of its properties or assets, and
(E) does not otherwise require any Governmental Approvals or, assuming the accuracy of the
representations and warranties of the Company under Section 2.1, any Third Party Consents.

ARTICLE III

COVENANTS

Section 3.1 Reserved Matters. The Company shall not, and shall cause each Subsidiary
of the Company not to, engage in any of the following matters without the prior written consent and
approval of the Investor:

(a) Alter, change, amend or repeal the Constituent Documents of the Company (including any
amendment effected by operation of law) that would contravene the protections of Section 242(b)(2)
of the DGCL or that would require a class vote of the Preferred Stock under Section 242(b)(2) of
the DGCL if any shares of Preferred Stock were outstanding; provided, however, that
if shares of Preferred Stock are outstanding and all such shares are held by Investor Holders, this
Section 3.1(a) shall not be applicable to any amendment of the certificate of incorporation
of the Company (including an amendment effected by operation of law) as to which the holders of the
Preferred Stock would have a class vote;

(b) Take or consent to any action that would cause any Investor and/or any Person whose Equity
Interests in the Company must be aggregated with those of an Investor for purposes of the BHC Act,
individually or collectively, to Beneficially Own more than 9.99% of any class of Voting Shares
(other than an action by an Investor Holder or any such Person), including through buy-backs of
Shares, reverse stock splits, or issuances of Shares; provided, however, that for
purposes of this Section 3.1(b) Beneficial Ownership by the Investor shall be calculated
without regard to Voting Shares acquired by the Investor after the Initial Closing (as defined in
the Purchase Agreement) (other than Voting Shares acquired pursuant to a Cure Purchase (for the
avoidance of doubt, only the number of shares required to offset the dilution in the related
Dilution Notice shall not be deemed to be Beneficially Owned for this purpose));

(c) Purchase or redeem any shares of Common Stock other than (i) a purchase or redemption to
which Section 4.3 applies, (ii) a purchase or redemption in which a pro rata portion of the
Preferred Stock are purchased or redeemed on the same terms and conditions as applicable to the
other shares of Common Stock being so purchased or redeemed or (iii) a purchase or redemption (or
series of related purchases or redemptions) in which less than twenty-five percent (25%) of the
outstanding shares of Common Stock (determined as of immediately prior to such purchase or
redemption) is so purchased or redeemed.

Section 3.2 Notices and Access to Information; Cooperation.

(a) The Company shall provide the Investor (i) with prompt written notice of any amendment of
the Major Stockholders Agreement and (ii) with a copy of any written notice of breach or default
under the Major Stockholders Agreement promptly after the Company has delivered or received such
notice.

(b) To the extent required for the fulfillment of SEC reporting obligations or Federal Reserve
Bank reporting obligations applicable to the Investor or any Affiliate of the Investor (the
“Reporting Obligations”), upon reasonable prior notice, except as determined in good faith
to be necessary to (i) ensure compliance with any applicable Law, (ii) preserve any applicable
privilege (including the attorney-client privilege), or (iii) comply with any contractual
confidentiality obligations, the Company shall, and shall cause each of the Subsidiaries of the
Company to, (A) afford the Investor or the applicable Affiliate of the Investor reasonable access,
during normal business hours, to the properties, books and records of the Company and each
Subsidiary of the Company applicable to the Reporting Obligations, (B) furnish to the Investor or
the applicable Affiliate of the Investor such additional financial and other information regarding
the Company and its Subsidiaries as the Investor or the applicable Affiliate of the Investor may
reasonably request in respect of the Reporting Obligations, and (C) make reasonably available to
the Investor or the applicable Affiliate of the Investor those employees of the Company and its
Subsidiaries whose assistance, expertise, and recollections may be necessary to assist the Investor
or the applicable Affiliate of the Investor in connection with its inquiries to comply with the
Reporting Obligations; provided, that such investigation shall not unreasonably interfere
with the business or operations of the Company and its Subsidiaries and the Investor shall be
responsible for its own and any out-of-pocket expenses in connection with the access described
herein; provided, further, that the auditors and accountants of the Company or its
Subsidiaries shall not be obligated to make any work papers available to any Person except in
accordance with such auditors’ and accountants’ normal disclosure procedures and then only after
such Person has signed a customary agreement relating to such access to work papers in form and
substance reasonably acceptable to such auditors or accountants; provided, further,
that any information obtained by the Investor or any Affiliate of the Investor pursuant to this
Section 3.2(b) shall be used solely to comply with its Reporting Obligations and shall be
subject to the obligation to keep such information confidential in accordance with Section
3.4.

Section 3.3 Board of Directors.

(a) Designation of Director.

(i) The Investor Holders, collectively, shall be entitled to designate one Director to the
Board upon the terms and subject to the conditions of this Section 3.3(a) and the second
sentence of Section 3.3(b).

(ii) Except as provided in Section 3.3(a)(iv) and (a)(v) or as required by
applicable Law, no Director designated pursuant to this Section 3.3(a) may be removed from
office (whether or not for cause) unless such removal is directed or approved by the Investor
Holders.

(iii) Upon the death, disability, retirement, resignation or other removal by the Investor
Holders of the Director designated by the Investor Holders, the Board shall appoint as a Director
to fill the vacancy so created with an individual designated by the Investor Holders.

(iv) If the Investor Shares held by the Investor Holders (including, for the avoidance of
doubt, any issued Warrant Shares held by the Initial Holder) (the “Numerator Shares”)
represents less than 4% (as adjusted pursuant to the last sentence of this Section
3.3(a)(iv), the “Threshold Percentage”) of the sum of (x) Voting Shares (including, for the
avoidance of doubt, Investor Shares and issued Warrant Shares) and (y) the Conversion Shares
issuable to any DFR Holdings Holder upon the conversion of the aggregate amount of Convertible
Notes then outstanding (the “Denominator Shares”), in each case, calculated as of the close
of business on the last Trading Day of the month immediately prior to the date on which the
Nominating Committee designates the Independent Director nominees for election at the relevant
stockholder meeting, the Investor Holders shall not be entitled to designate a Director. To the
extent that the Investor Holders cease to have the right to designate a Director, if requested by a
majority of the Directors then serving on the Board (other than the Director designated by the
Investor Holders), the Investor Holders shall promptly take all necessary action to procure the
resignation of their designated Director; provided, that the Investor Holders shall not be
required to cause their designated Director to resign in accordance with this Section
3.3(a)(iv) as a result of a dilution of the Investor Shares (other than dilution resulting from
the issuance of New Shares) unless and until the Company complies with procedures in Section
3.3(a)(v) below. If the Initial Holder exercises all or any portion of the Warrant from time
to time, the Threshold Percentage shall automatically increase to an amount equal to (A) 4%, plus
(B) the aggregate number of Warrant Shares issued upon the exercise of the Investor Warrant by the
Initial Holder, divided by (C) the total number of Warrant Shares issuable under the Investor
Warrant as of the date hereof; provided, that for the avoidance of doubt, the Threshold
Percentage shall not exceed 5%.

(v) Notwithstanding anything in Section 3.3(a)(iv) to the contrary, if the Numerator
Shares represent a percentage of the Denominator Shares that is less than the Threshold Percentage
as a result of dilution of the Investor Shares, other than dilution resulting from the issuance of
New Shares, the Company shall deliver a written notice to the Investor Holders of such dilution
event (the “Dilution Notice”). If (A) within twenty (20) days following receipt of the
Dilution Notice, the Investor Holders give the Company a written notice of their intention to
acquire, directly or indirectly, an amount of Voting Shares or other Shares, such that immediately
following such acquisition the Numerator Shares represent a percentage of Denominator Shares equal
to the Threshold Percentage of the Denominator Shares (a “Cure Purchase”) within ninety
(90) days of the Company’s receipt of the Dilution Notice (the “Cure Period”) and (B) the
Cure Purchase is consummated during the Cure Period, then the Investor Holders shall not be
required to cause their designated Director to resign in accordance with Section
3.3(a)(iv).

(vi) The Company shall cause each individual designated in accordance with Section
3.3(a)(i) to be included in the Board’s “slate” of nominees for the applicable meeting of
stockholders and shall use commercially reasonable best efforts to solicit from its Stockholders
eligible to vote for the election of Directors proxies (A) in favor of the election of such
individuals and (B) against removal of each such individual (to the extent such individual is
serving as a Director). In the event that, notwithstanding the foregoing, such individual is not
elected to, or is removed from (other than by the Investor Holders) the Board, the Company shall
create a vacancy on the Board and appoint such individual to fill such vacancy.

(vii) Until the first annual meeting of Stockholders of the Company for the election of
Directors held after the first anniversary of this Agreement, the Director designated by the
Investor Holders shall receive no compensation or benefits, other than reimbursement for travel,
lodging and related expenses incurred in connection with meetings of the Board or any committee
thereof, or otherwise in service as a Director or member of the boards of directors of the Company
or any of its Subsidiaries in accordance with the Company’s policies applicable to the other
outside directors. Thereafter, the compensation and benefits of such Director shall be determined
with the approval of a majority of the Board and a majority of Independent Directors.

(viii) Notwithstanding anything to the contrary in Section 3.3(a)(vii), the Company
shall to the maximum extent permitted under applicable Law, indemnify and provide for the
advancement of expenses to the Director designated by the Investor Holders, from and against any
and all losses which may be imposed on, incurred by, or asserted against such Director in any way
relating to or arising out of, or alleged to relate to or arise out of, the Director’s service in
that capacity pursuant to the Company’s Constituent Documents and an indemnification agreement in
the form heretofore provided to the Investor.

(ix) The Director designated by the Investor Holders shall be covered by the directors’ and
officers’ liability insurance and fiduciary liability insurance carried by the Company.

(x) No Investor Holder, nor any Affiliate of any Investor Holder, shall have any liability as
a result of designating an individual for election as a Director for any act or omission by such
designated individual in his or her capacity as a Director of the Company, nor shall any Investor
Holder have any liability as a result of voting for any such designee in accordance with the
provisions of this Agreement.

(xi) Any Person designated as a Director pursuant to Section 3.3(a)(i) by the Investor
Holders shall be subject to satisfaction of the requirements of applicable Law and corporate
governance policies adopted by the Board.

(xii) The Investor Holders may waive their right to designate a Director under this
Section 3.3 at any time by delivering written notice of such waiver to the Company in
accordance with Section 5.4; provided, however, that the Investor Holders
shall not be entitled to rescind any such waiver once delivered. If the Investor Holders otherwise
lose their right to designate a Director pursuant to Section 3.3(a)(iv) and (a)(v),
the Investor Holders shall not be entitled to regain their right to designate such Director, even
if the Numerator Shares represent a percentage of the Denominator Shares that is equal to or
greater than the Threshold Percentage.

(b) If at any time there is no Director on the Board that is designated by the Investor
Holders and at such time the Total Investor Shares held by the Investor Holders represent greater
than or equal to 5% of the Total Shares, the Investor Holders shall be entitled to designate one
observer (the “Observer”) to attend (but not vote at) all meetings of the Board and each
committee of the Board (including meetings held by means of conference telephone or other similar
means). Following the designation of such Observer, the Investor Holders’ right to designate a
Director under Section 3.3(a) shall be automatically suspended until such time as the
Observer resigns or is removed by the Investor Holders. The Company shall deliver, or cause to be
delivered, to the Observer copies of all notices, agendas, minutes, written consents and other
materials that it provides to the Board at the same time and in the same manner provided to the
Board. Notwithstanding anything herein to the contrary, the Board or such committee may exclude
the Observer from access to any materials or meeting or portion thereof if (i) the Board or such
committee (as applicable) determines in good faith to so exclude the Observer, including if the
Board or such committee (as applicable) determines in good faith that, (A) such exclusion is
required under applicable Law or (B) upon advice of counsel, such exclusion is reasonably necessary
to preserve the attorney-client privilege or (ii) the Observer has not entered into a
confidentiality agreement in form and substance reasonably satisfactory to the Company. If at any
time the Investor Holders have exercised their rights under this Section 3.3(b) to
designate the Observer, and thereafter the Investors Holders subsequently no longer have the right
to designate the Observer, the Investor Holders shall take all necessary action to remove the
Observer from the Board.

Section 3.4 Confidentiality.

(a) Each Investor Holder agrees that it shall (and shall cause any of its Affiliates and its
and their officers, directors, employees, partners and agents (collectively, the
“Confidentiality Affiliates”) in possession of Confidential Information to) (i) hold
confidential and not disclose (other than by an Investor Holder to its Confidentiality Affiliates
having a reasonable need to know in connection with the permitted purposes hereunder), without the
prior written consent of the Company, all confidential or proprietary written, recorded or oral
information or data provided or developed by, or concerning, the Company or another Stockholder in
connection herewith or with the business of the Company and its Affiliates, including any
information obtained by such Investor Holder pursuant to Section 3.2 or Section 3.3
or any information obtained from any Observer or Director designated by the Investor Holders
obtained by any such Person in his or her capacity as such, whether such confidentiality or
proprietary status is indicated orally or in writing or in a context in which the Company
reasonably communicated, or the receiving Stockholder should reasonably have understood, that the
information should be treated as confidential, whether or not the specific words “confidential” or
“proprietary” are used (“Confidential Information”) and (ii) use such Confidential
Information only for the purposes of performing its obligations hereunder and monitoring its
investment in the Company.

(b) The obligations contained in this Section 3.4 shall not apply, or shall cease to
apply, to Confidential Information if or when, and to the extent that, such Confidential
Information (i) is, or becomes through no breach of the Investor Holders obligations hereunder,
generally known to the public, (ii) becomes known to the Investor Holders or their Confidentiality
Affiliates from other sources under circumstances not involving any breach of any confidentiality
obligation between such source and the Company, (iii) is independently developed by the Investor
Holders or their Confidentiality Affiliates, or (iv) is required, as determined based on the advice
of its legal counsel, to be disclosed by applicable Law, in which case only that portion of the
Confidential Information legally required to be so disclosed, based on the advice of counsel, shall
be disclosed and the Investor Holders shall use commercially reasonable efforts to obtain assurance
that confidential treatment will be accorded to such disclosed Confidential Information;
provided, that prior to any disclosure pursuant to clause (iv) of this Section
3.4(b), the Investor Holders shall provide the Company with prompt notice of such disclosure,
and a description of the Confidential Information to be disclosed and the terms and circumstances
surrounding the requirement to disclose such Confidential Information, to enable the Company to
seek an appropriate protective order or other appropriate remedy, or, if agreed to by the Investor
and the Company, waive compliance with the terms of this Section 3.4; provided,
further, that the Investor Holders shall cooperate and assist the Company in seeking a
protective order or other appropriate remedy and the Company shall reimburse the Investor Holders
for all reasonable out-of-pocket expenses incurred by the Investor Holders in providing such
cooperation and assistance; provided, however, that no consent of, or notice to,
the Company shall be required for the Investor Holders to disclose the fact that such Persons are
Stockholders and such Persons’ ownership percentage in the Company, in each case to comply with the
Reporting Obligations.

Section 3.5 Purchase of Voting Shares. The Investor Holders shall not take or consent
to any action that would cause any Investor and/or any Person whose Equity Interests in the Company
must be aggregated with those of an Investor for purposes of the BHC Act, individually or
collectively, to Beneficially Own more than 9.99% of any class of the Company’s Voting Shares.

ARTICLE IV

PREEMPTIVE RIGHTS AND TRANSFER PROVISIONS

Section 4.1 Preemptive Rights.

(a) For so long as the Investor Holders collectively hold Numerator Shares and Warrant Shares
issuable to the Initial Holder upon exercise of the Warrant (together, the “Total Investor
Shares”) representing at least five percent (5%) of the Denominator Shares and the Warrant
Shares issuable to the Initial Holder upon exercise of the Warrant (together, the “Total
Shares”), each Investor Holder shall have the right to purchase, in accordance with the
procedures set forth herein, its pro rata portion, calculated based on the number of Total Investor
Shares as a percentage of the Total Shares prior to issuance of the New Shares (the Investor
Holders’ “Pro Rata Portion”) of any New Shares that the Company may, from time to time,
propose to sell and issue (hereinafter referred to as the “Preemptive Right”).

(b) In the event that the Company proposes to issue and sell New Shares, the Company shall
notify each Investor Holder in writing with respect to the proposed New Shares to be issued (the
“New Shares Notice”). Each New Shares Notice shall set forth: (i) the number of New Shares
proposed to be issued by the Company and the purchase price therefor; (ii) the Investor Holders’
Pro Rata Portion of such New Shares; and (iii) any other material term (including, if known, the
expected date of consummation of the purchase and sale of the New Shares). Failure to deliver the
New Shares Notice pursuant to the foregoing shall not affect the legality or validity of the
Preemptive Right.

(c) Each Investor Holder shall be entitled to exercise its right to purchase New Shares by
delivering an irrevocable written notice to the Company within fifteen (15) days from the date of
receipt of any such New Shares Notice specifying the number of New Shares to be subscribed, which
in any event can be no greater than the Investor Holders’ Pro Rata Portion of such New Shares at
the price and on the terms and conditions specified in the New Shares Notice.

(d) If an Investor Holder does not elect within the applicable notice period described above
to exercise its Preemptive Rights with respect to any of the New Shares proposed to be sold by the
Company, the Company shall have ninety (90) days after expiration of such notice period to sell
such unsubscribed New Shares proposed to be sold by the Company, at a price and on terms no more
favorable to the purchaser than those set forth in the New Shares Notice. If the Company does not
consummate the sale of the unsubscribed New Shares in accordance with the terms of the New Shares
Notice within such ninety (90)-day period, then the Company may not issue or sell such New Shares
unless it sends a new New Shares Notice and once again complies with the provisions of this
Section 4.1 with respect to such New Shares.

(e) Each Investor Holder shall take up and pay for any New Shares that such Investor Holder
has elected to purchase pursuant to the Preemptive Right upon closing of the issuance of the New
Shares, and shall have no right to acquire such New Shares if the issuance thereof shall not be
consummated.

Section 4.2 Voting Rights Notwithstanding any other provision contained herein, if at
any time the Investor Shares represent more than 4.99% of any class of Voting Shares (including as
a result of any Investor Holder’s exercise of the Preemptive Right or a Cure Purchase hereunder),
the Investor and its Affiliates collectively shall be deemed to have voting rights in respect of
only 4.99% of such class of Voting Shares, such voting rights in excess of said 4.99% shall be
relinquished and Shares corresponding to such excess (the “Excess Shares”) shall be deemed
to be non-voting Shares of the same class, which Shares shall be identical in all respects,
excepting voting rights, to other Shares in such class. The voting restriction set forth in the
first sentence of this Section 4.2 (the “Voting Restriction”) shall continue to
apply following any Transfer of such Excess Shares; provided, that the Voting Restriction
shall not continue to apply:

(a) to any transferee of the Excess Shares that is not a Person whose Equity Interests in the
Company must be aggregated with those of the Investor for purposes of the BHC Act; or

(b) to the Investor and its Affiliates, at such time as the number of Voting Shares (including
Excess Shares that would be Voting Shares but for the Voting Restriction) Beneficially Owned, or
otherwise held or controlled (in each case, directly or indirectly) by the Investor and its
Affiliates is equal to or less than 4.99% of the applicable class of Voting Shares.

Section 4.3 Tag-Along Rights.

(a) Subject to Section 4.4, if at any time either or both Major Stockholder(s) (each,
a “Tag-Along Seller”) proposes to enter into a Transfer of its Shares (including a Transfer
to the Company) (a “Tag Transfer”), the Tag-Along Seller(s) shall first, by written notice
to the Company (and the Company shall promptly provide the Investor Holders with a copy of such
notice (the “Tag Transfer Notice”)), offer the Investor Holders the opportunity to
participate in such Tag Transfer (the “Tag-Along Offer”) in accordance with this
Section 4.3; provided, however, that this Section 4.3 shall not
apply, and a Transfer shall not be deemed to be a “Tag Transfer”:

(i) if the Tag-Along Seller is a DFR Holdings Holder and the Shares to be Transferred in the
Tag Transfer, together with all Shares Transferred by the DFR Holdings Holders from the Closing
through the date of the Tag Transfer, represent, in the aggregate, less than ten percent (10%) of
the sum of the (A) Shares held by the DFR Holdings Holders and (B) the Conversion Shares issuable
to any DFR Holdings Holder upon the conversion of the aggregate amount of Convertible Notes then
outstanding, in each of clauses (A) and (B), as of the Closing;

(ii) if the Tag-Along Seller is a CIFC Holder and the Shares to be Transferred in the Tag
Transfer, together with all Shares Transferred by the CIFC Holders from the Closing through the
date of the Tag Transfer, represent, in the aggregate, less than ten percent (10%) of the Shares
held by the CIFC Holders as of the Closing;

(iii) any Transfer to an Affiliate of the Tag-Along Seller; or

(iv) to any Transfer pursuant to a registered public offering in accordance with the
Registration Rights Agreement (which shall also not be included for purposes of determining whether
the thresholds set forth in clauses (i) and (ii) of this Section 4.3(a)
have been reached).

(b) The Tag Transfer Notice shall identify: (i) the class and number of Shares proposed to be
sold by the Tag-Along Seller(s); (ii) an estimate of the Tag-Along Percentage; (iii) the
consideration for which the Tag Transfer is proposed to be made, (iv) the name of each proposed
transferee, (v) the proposed Tag Transfer date and (vi) all other material terms and conditions of
the Tag-Along Offer, including the form of the proposed agreement, if any.

(c) From the date of their receipt of the Tag Transfer Notice, the Investor Holders shall have
the right (the “Tag-Along Right”) exercisable by written notice (“Tag Exercise
Notice”) given to the Tag-Along Seller(s) within ten (10) days after receipt of the Tag
Transfer Notice (the “Tag-Along Notice Period”), to request that the Tag-Along Seller(s)
include in the Tag Transfer a number of Investor Shares and/or issued Warrant Shares (such number
of Investor Shares and/or issued Warrant Shares shall not in any event exceed the Tag-Along
Percentage of the total number of the Shares to be Transferred in such Tag Transfer) (the “Tag
Shares”); provided, however, that if Warrant Shares are included in the Tag
Shares, the Investor Holders shall be required to exercise all or the applicable portion of the
Warrant prior to or in connection with such Tag Transfer. The Tag Exercise Notice shall include
wire transfer instructions for payment of the purchase price for the Tag Shares. If the Investor
Holders exercise their Tag-Along Right hereunder, they shall, upon request, deliver to the
Tag-Along Seller(s), with the Tag Exercise Notice, the certificate(s) representing the Tag Shares,
together with a limited power-of-attorney authorizing the Tag-Along Seller(s) to Transfer the Tag
Shares on the terms set forth in the Tag Transfer Notice. The Investor Holders’ delivery of the
Tag Exercise Notice with such certificate(s) and the limited power-of-attorney shall constitute an
irrevocable acceptance of the Tag-Along Offer by such Investor Holders (the “Tagging
Investors”). Subject to Section 4.4(b), in order to participate in a Tag Transfer
hereunder, the Tagging Investors must agree to enter into and execute substantially identical
agreements and documents as entered into and executed by the Tag-Along Seller(s) in connection with
the Tag Transfer.

(d) The number of Shares to be Transferred by the Tag-Along Seller(s) in the Tag Transfer
shall be reduced by the number of Tag Shares to be Transferred in such Tag Transfer by the Investor
Holders.

(e) If, at the end of a 120-day period after the date of receipt of the Tag Transfer Notice
(which 120-day period shall be extended if any of the transactions contemplated by the Tag-Along
Offer are subject to regulatory approval until the expiration of five (5) Business Days after all
such approvals have been received, but in no event later than 180 days after the date of receipt of
the Tag Transfer Notice), the Tag Transfer has not been completed by the Tag-Along Seller(s) on
substantially the same terms and conditions set forth in the Tag Transfer Notice (but as to price,
the terms shall be exactly the same), the applicable Tag-Along Seller shall (i) promptly return to
the Tagging Investors the limited power-of-attorney (and all copies thereof) together with all
certificates representing the Tag Shares that such Tagging Investors delivered for Transfer
pursuant to this Section 4.3 and any other documents in the possession of such Tag-Along
Seller executed by the Tagging Investors in connection with the proposed Tag Transfer, and (ii) not
proceed with the contemplated Tag Transfer without again complying with this Section 4.3.

(f) Concurrently with the consummation of the Tag Transfer, the Tag-Along Seller(s) shall (i)
notify the Tagging Investors thereof, (ii) remit or cause to be remitted to the Tagging Investors
the total consideration to be paid at the closing of the Tag Transfer for the Tag Shares
Transferred pursuant thereto, with the cash portion of the purchase price paid by wire transfer of
immediately available funds in accordance with the wire transfer instructions in the Tag Exercise
Notice, and (iii) promptly after consummation of such Tag Transfer, furnish such other evidence of
the completion and the date of completion of such Transfer and the terms thereof as may be
reasonably requested by the Tagging Investors.

(g) If, at the termination of the Tag-Along Notice Period, any Investor Holder has not elected
to participate in the Tag Transfer, such Investor Holder shall be deemed to have waived its rights
under this Section 4.3 with respect to, and only with respect to, the Transfer of its
Investor Shares or Warrant Shares in connection with the Tag Transfer described in the Tag Transfer
Notice delivered at the beginning of such Tag-Along Notice Period.

(h) Notwithstanding anything contained in this Section 4.3 there shall be no liability
on the part of the Tag-Along Seller to the Tagging Investors (other than the obligation to return
any certificates evidencing Tag Shares and limited powers-of-attorney received by the Tag-Along
Seller) if a Tag Transfer under this Section 4.3 is not consummated for whatever reason.
The decision to effect a Tag Transfer pursuant to this Section 4.3 by a Tag-Along Seller is
in the sole and absolute discretion of such Tag-Along Seller.

Section 4.4 Additional Provisions Related to Tag Transfers. Notwithstanding anything
contained in Section 4.3 to the contrary, in connection with a Tag Transfer under
Section 4.3:

(a) Upon the consummation of such Tag Transfer, all Investor Holders participating therein
will receive the same form and amount of consideration per share as the Major Stockholders
participating therein, or, if any Major Stockholder is given an option as to the form and amount of
consideration to be received, the Investor Holders participating therein will be given the same
option; provided, that to the extent the Investor Holders Transfer unissued Warrant Shares
in such Tag Transfer, the consideration payable to such Investor Holders shall be reduced by the
aggregate Exercise Price of such Warrant Shares.

(b) Each Investor Holder shall (i) make such representations, warranties and covenants and
enter into such definitive agreements as are customary for transactions of the nature of the
proposed Transfer, (ii) benefit from and be subject to all of the same provisions of the definitive
agreements as are applicable to the Tag-Along Seller, (iii) be required to bear its proportionate
share of any escrows, holdbacks or adjustments in respect of the purchase price or indemnification
obligations; provided, that no Investor Holder shall be obligated (A) to indemnify, other
than severally indemnify, any Person in connection with such Tag Transfer, (B) to incur liability
to any Person in connection with such Tag Transfer, including, without limitation, under any
indemnity, in excess of the lesser of (1) its pro rata share of such liability and (2) the proceeds
realized by such Investment Holder in such sale (provided, that the case of this clause
(B) of Section 4.4(b)(iii), no such limitation shall apply to any breach of any
representations or warranties made by, or breach of any obligation of, such Investment Holder), or
(C) in its capacity as a Stockholder, to agree to any non-competition or non-solicitation
restrictions which are more restrictive on such Investor Holder than those restrictions agreed to
by such Investor Holder in this Agreement or the Purchase Agreement, and (iv) cooperate in
obtaining all Governmental Approvals and Third-Party Consents reasonably necessary or desirable to
consummate such Tag Transfer.

(c) In the event the consideration to be paid in exchange for Shares in a Tag Transfer
includes any securities, and the receipt thereof by an Investor Holder would require under
applicable Law (i) the registration or qualification of such securities or of any Person as a
broker or dealer or agent with respect to such securities where such registration or qualification
is not otherwise required for the Tag Transfer or (ii) the provision to any Tag-Along Seller of any
specified information regarding such securities or the issuer thereof that is not otherwise
required to be provided for the Tag Transfer, then such Investor Holder shall not have the right to
sell Investor Shares and/or Warrant Shares in such proposed Tag Transfer. In such event, the
Tag-Along Seller shall have the right, but not the obligation, to cause to be paid to such Investor
Holder in lieu thereof, against surrender of the Investor Shares and/or Warrant Shares that would
have otherwise been Transferred by such Investor Holder to the prospective purchaser in the
proposed Tag Transfer, an amount in cash equal to the fair market value (as determined in the
reasonable determination of the Board) of such Investor Shares and/or Warrant Shares as of the date
such securities would have been issued in exchange for such Investor Shares and/or Warrant Shares.

(d) Each Tagging Investor shall bear an amount of the reasonable costs and expenses incurred
by the Tag-Along Seller or the Company in connection with any proposed Tag Transfer (whether or not
consummated), including reasonable and documented attorneys’ fees and charges, all accounting fees
and charges and all finders, brokerage or investment banking fees, charges or commissions, pro rata
in proportion to the amount transferred or proposed to be transferred by such Tagging Investor as
compared to the aggregate amount transferred or proposed to be transferred by the Tag-Along Seller
and all Tagging Investors; provided, that, in connection with any Tag Transfer, each
Tagging Investor shall bear in its entirety any attorneys’ fees and charges, accounting fees and
charges and any other advisor fees, charges or commissions incurred by such Tagging Investor in
connection with such Tag Transfer.

Section 4.5 Transfer of Investor Shares.

(a) Any Investor Holder may Transfer to one or more Persons at any time, without the consent
of the Company or any other Stockholder, all or any portion of the Shares held by such Investor
Holder.

(b) Notwithstanding anything to the contrary herein, the rights and obligations of the
Investor Holders hereunder are personal to such Investor Holders and shall not be assigned, by
operation of law or otherwise, except to an Investor Holder or a Person that would be an Investor
Holder after giving effect to the Transfer. Prior to or in connection with the Transfer of any
Shares owned by the Investor (or an Investor Holder) to an Affiliate of the Investor, such Investor
shall deliver to the Company a “statement of adhesion” pursuant to which such Investor Holder
confirms its agreement to be subject to and bound by all of the provisions set forth in this
Agreement that were applicable to the Investor (or Investor Holder).

(c) For the avoidance of doubt, any Transfer of Shares pursuant to a registration statement or
Rule 144 or to any Person that is not an Affiliate of the Investor (other than a Person not
Affiliated with the Investor that is acquiring all or substantially all of the Investor Holders’
Shares pursuant to Section 4.5(b)) shall be free and clear of the restrictions contained in
this Agreement and the transferee shall not acquire any rights under this Agreement.

ARTICLE V

MISCELLANEOUS

Section 5.1 Termination of Agreement.

(a) This Agreement shall continue in effect until:

(i) Terminated by written agreement of the Company and the Investor; or

(ii) Terminated by the Company with fifteen (15) days’ prior written notice to the Investor
Holders (the “Termination Notice”) upon such time as the Total Investor Shares held by the
Investor Holders represent less than five percent (5%) of the sum of the Voting Shares and the
Warrant Shares issuable to the Initial Holder upon exercise of the Investor Warrant;
provided, however, that this Section 5.1(a)(ii) shall apply only if, prior
to delivery by the Company of the Termination Notice to the Investor Holders, the Company has
delivered to the Investor Holders a Dilution Notice in accordance with Section 3.3(a)(v)
hereof (mutatis mutandis) and the Investor Holders have not, within the respective time periods
specified in Section 3.3(a)(v) (mutatis mutandis), given the Company written notice of
their intention to effect a Cure Purchase and consummated such Cure Purchase.

(b) Section 3.4 (Confidentiality) shall survive the termination of this Agreement.

Section 5.2 Dispute Resolution.

(a) Except with respect to any request for equitable relief (including interim relief), any
dispute, controversy or claim arising out of or relating to the transactions contemplated by this
Agreement, or the validity, interpretation, breach or termination of this Agreement, including
claims seeking redress or asserting rights under any Law (a “Dispute”), shall be resolved
in accordance with the procedures set forth in this Section 5.1. Until completion of such
procedures, no party may take any action to force a resolution of a Dispute by any judicial or
similar process, except to the limited extent necessary to (i) avoid expiration of a claim that
might eventually be permitted by this Agreement or (ii) obtain equitable relief; provided,
that the rights reserved in clause (i) of Section 5.2(a) may be exercised within three (3)
months prior to the expiration of the applicable claim.

(b) Any Party seeking resolution of a Dispute shall first serve on the other a notice (an
“Escalation Notice”) specifying the details of the relevant Dispute and requiring that such
Dispute be referred to the Parties’ Representatives set out in Schedule 5.2(b). In the
event that the Parties’ Representatives are unable to resolve such disagreement within fifteen (15)
Business Days following the Escalation Notice, either Party may submit the Dispute for resolution
by mediation pursuant to the International Institute for Conflict Prevention & Resolution Mediation
Procedure as then in effect. Mediation will continue for at least thirty (30) days from the date
such mediation was commenced, unless the mediator chooses to withdraw sooner.

(c) All offers of compromise or settlement among the parties in connection with the attempted
resolution of any Dispute shall be deemed to have been delivered in furtherance of a Dispute
settlement and shall be exempt from discovery and production and shall not be admissible in
evidence (whether as an admission or otherwise) in any proceeding for the resolution of the
Dispute.

(d) For the avoidance of doubt, the Parties agree that either of them may seek interim
measures including injunctive relief in relation to the provisions of this Agreement or the
Parties’ performance of it from any New York Court.

Section 5.3 Expenses. Except as otherwise expressly set forth herein, each Party
hereto shall pay its own costs and expenses (including all legal, accounting, broker, finder and
investment banker fees) relating to this Agreement, the negotiations leading up to this Agreement
and the transactions contemplated hereby.

Section 5.4 Notices. Except as otherwise expressly set forth herein, all notices,
demands and other communications pertaining to this Agreement (“Notices”) shall be in
writing and addressed as follows:

	 
	If to the Company:
	CIFC Corp.
	250 Park Avenue, 4th Floor
	New York, NY 10177
	Attention: Robert C. Milton III, Esq.
	Email: rmilton@cifc.com
	with copies to:
	Goodwin Procter LLP
	Exchange Place
	53 State Street
	Boston, MA 02109
	Attention: John Mutkoski, Esq.; Amber R.E. Dolman, Esq.
	E-mail: jmutkoski@goodwinprocter.com; adolman@goodwinprocter.com
	If to the Investor:

	GE Capital Equity Investments, Inc.

201 Merritt 7

Norwalk, CT 06856

Attention: CIFC Account Manager

E-mail: equity.portfolio@ge.com

	with copies to:

	Allen & Overy LLP

1221 Avenue of the Americas

New York, NY 10020

Attention: Eric S. Shube, Esq.

E-mail: eric.shube@allenovery.com

	 

Notices shall be deemed given (a) on the first (1st) Business Day after being sent, prepaid, by
nationally recognized overnight courier that issues a receipt or other confirmation of delivery,
(b) when sent, if sent by electronic mail before 5:00 p.m. on a Business Day at the location of
receipt and otherwise the next following Business Day. Any Party may change the address to which
Notices under this Agreement are to be sent to it by giving written notice of a change of address
in the manner provided in this Agreement for giving Notice.

Section 5.5 Governing Law. EXCEPT TO THE EXTENT THAT THE LAWS OF THE STATE OF
DELAWARE APPLICABLE TO THE ELECTION OR REMOVAL OF DIRECTORS ARE APPLICABLE, THIS AGREEMENT (AND ANY
CLAIMS OR DISPUTES ARISING OUT OF OR RELATED HERETO OR TO THE TRANSACTIONS CONTEMPLATED HEREBY OR
TO THE INDUCEMENT OF ANY PARTY TO ENTER HEREIN, WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR
OTHERWISE AND WHETHER PREDICATED ON COMMON LAW, STATUTE OR OTHERWISE) SHALL IN ALL RESPECTS BE
GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW
YORK WITHOUT REFERENCE TO ITS CHOICE OF LAW RULES THAT WOULD APPLY THE LAWS OF ANY OTHER
JURISDICTION.

Section 5.6 Submission to Jurisdiction. Each of the Parties agrees that if any
Dispute is not resolved pursuant to the procedures set forth in Section 5.2, such Dispute
shall be resolved only in the State Courts of the State of New York, New York County or the United
States District Court located in the State of New York, New York County (the “New York
Courts,” and each, a “New York Court”). In that context, and without limiting the
generality of the foregoing, each of the Parties by this Agreement irrevocably and unconditionally:

(a) submits for itself and its property in any Action relating to this Agreement, or for
recognition and enforcement of any judgment in respect thereof, to the exclusive jurisdiction of
the New York Courts, and agrees that all claims in respect of any such Action shall be heard and
determined in the New York Courts;

(b) consents that any such Action may and shall be brought in the New York Courts and waives
any objection that it may now or hereafter have to the venue or jurisdiction of any such Action in
the New York Courts or that such Action was brought in an inconvenient court and agrees not to
plead or claim the same;

(c) agrees that service of process in any such Action may be effected by mailing a copy of
such process by registered or certified mail (or any substantially similar form of mail), postage
prepaid, to such party at its address as provided in Section 5.4; and

(d) agrees that nothing in this Agreement shall affect the right to effect service of process
in any other manner permitted by the Laws of the State of New York.

Section 5.7 Specific Performance. The Parties to this Agreement each acknowledge that
each Party would not have an adequate remedy at law for money damages in the event that any of the
covenants hereunder have not been performed in accordance with their terms, and therefore agree
that each other Party hereto shall be entitled to specific enforcement of the terms hereof and any
other equitable remedy to which such Party may be entitled. Each of the Parties hereby waives
(i) any defenses in any action for specific performance, including the defense that a remedy at law
would be adequate and (ii) any requirement under any Law to post a bond or other security as a
prerequisite to obtaining equitable relief.

Section 5.8 Waiver of Jury Trial. THE PARTIES EACH HEREBY WAIVE TRIAL BY JURY IN ANY
JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTERS (WHETHER SOUNDING IN TORT,
CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO OR CONNECTED WITH THIS AGREEMENT OR
THE TRANSACTIONS CONTEMPLATED HEREBY.

Section 5.9 Binding Effect; Persons Benefiting; Assignment.

(a) This Agreement shall inure to the benefit of and be binding upon the Parties hereto and
their respective successors and permitted assigns including an Investor Holder who takes in
accordance with Section 4.5(b). Nothing in this Agreement is intended or shall be
construed to confer upon any Person any right, remedy or claim under or by reason of this Agreement
or any part hereof other than the Parties hereto and their respective successors and permitted
assigns.

(b) Without the prior written consent of the other party hereto, this Agreement may not be
assigned by either party hereto, and any purported assignment made without such consent shall be
null and void.

Section 5.10 Counterparts. This Agreement may be executed in counterparts (including
by facsimile or other electronic transmission), each of which shall be deemed an original and each
of which shall constitute one and the same instrument.

Section 5.11 Entire Agreement. This Agreement, including the Schedules, Exhibits,
Annexes, certificates and lists referred to herein, any documents executed by the Parties
simultaneously herewith or pursuant thereto constitute the entire understanding and agreement of
the Parties hereto with respect to the subject matter hereof and supersedes all other prior
agreements and understandings, written or oral, between the Parties with respect to such subject
matter.

Section 5.12 Severability. If any provision of this Agreement, or the application
thereof to any Person or circumstance, is invalid or unenforceable in any jurisdiction, (a) a
substitute and equitable provision shall be substituted therefor in order to carry out, so far as
may be valid and enforceable in such jurisdiction, the intent and purpose of their invalid or
unenforceable provision; and (b) the remainder of this Agreement and the application of such
provision to other Persons or circumstances shall not be affected by such invalidity or
unenforceability, nor shall such invalidity or unenforceability of such provision affect the
validity or enforceability of such provision, or the application thereof, in any other
jurisdiction.

Section 5.13 Amendments and Waivers. This Agreement may not be amended, altered or
modified except by written instrument executed by the Investor and the Company. The failure by any
Party hereto to enforce at any time any of the provisions of this Agreement shall in no way be
construed to be a waiver of any such provision nor in any way to affect the validity of this
Agreement or any part hereof or the right of such Party thereafter to enforce each and every such
provision. No waiver of any breach of or non-compliance with this Agreement shall be held to be a
waiver of any other or subsequent breach or non-compliance. Any waiver made by any Party hereto in
connection with this Agreement shall not be valid unless agreed to in writing by such Party.

Section 5.14 Delays or Omissions. No delay or omission to exercise any right, power,
or remedy accruing to any Party under this Agreement shall impair any such right, power, or remedy
of such Party, nor shall it be construed to be a waiver of or acquiescence to any breach or
default, or of or in any similar breach or default thereafter occurring; nor shall any waiver of
any single breach or default be deemed a waiver of any other breach or default. All remedies,
either under this Agreement or by law or otherwise afforded to any holder, shall be cumulative and
not alternative.

Section 5.15 Mutual Drafting; Interpretation. Each Party hereto has participated in
the drafting of this Agreement, which each such Party acknowledges is the result of extensive
negotiations between the Parties. If an ambiguity or question of intent or interpretation arises,
this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or
burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any
provision.

[Remainder of Page Left Blank]

3

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above
written.

	 	 	 
	 	 	COMPANY:

	 	 	CIFC CORP.

	 	 	By: /s/ Robert C. Milton III

	 	 	 

	                    
	 	Name: Robert C. Milton, III        

	                    
	 	Title: Secretary and General Counsel

	 	 	INVESTOR:

	 	 	GE CAPITAL EQUITY INVESTMENTS, INC.

	 	 	By: /s/ Shin Kimura

	 	 	 

	 	 	Name: Shin Kimura

	 	 	Title: Vice President

4

Schedule 2.1(d)

Consents

5

6

Schedule 5.2(b)

Dispute Resolution Representatives

Investor

Shin Kimura

Bill Orr

The Company

Robert C. Milton III

Gary Neems

7EX-10.4

Exhibit 10.4

THE SECURITIES OF THE ISSUER REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR THE STATE SECURITIES LAWS OF ANY STATE. WITHOUT SUCH
REGISTRATION, SUCH SECURITIES MAY NOT BE SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED AT
ANY TIME WHATSOEVER, EXCEPT PURSUANT TO AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS.

No. of Shares of Common Stock or Preferred Stock, as applicable: 2,000,000 Warrant No. A-1

WARRANT

to Purchase

Common Stock or Preferred Stock of

CIFC Corp.

THIS IS TO CERTIFY THAT, for value received, GE Capital Equity Investments, Inc., a Delaware
corporation (“GECEI,” and, together with any successor or registered assign that is GECC or
any Person whose Equity Interests in the Issuer must be aggregated with those of GECC for purposes
of the BHC Act, the “Initial Holder”), is entitled to purchase in whole or in part from
time to time from CIFC Corp., a Delaware corporation (together with any successor thereto, the
“Issuer”), at any time during the Exercise Period, the number of Warrant Shares (subject to
adjustment as provided herein) shown above at a purchase price of $6.375 per Warrant Share (subject
to adjustment as provided herein) (the “Exercise Price”). Certain capitalized terms used
in this Warrant are defined in Section 1.02.

This warrant to Purchase Common Stock or Preferred Stock (this “Warrant,” and
collectively with any other Warrants to Purchase Common Stock or Preferred Stock issued upon any
transfer of all or a portion of this Warrant, the “Warrants”) has been issued pursuant to
the Purchase Agreement.

As further set forth herein: (a) Common Stock shall be issuable in connection with any
exercise of this Warrant by any Other Holder; and (b) only Preferred Stock shall be issuable in
connection with any other exercise of this Warrant.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Warrant, and for
other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged,
the parties hereto agree as follows:

	 	 	 	 	 
	SECTION 1.Certain Definitions.
	 
	 	1.01	 	 	Reserved.

	 	 	 	 	 

1.02 Other Definitions. As used herein, the following terms shall have the following
meanings (all terms defined in this Section 1.02 or in other provisions of this Warrant in
the singular shall have the same meanings when used in the plural and vice versa):

“Action” means any judicial, legislative, administrative or arbitral actions, suits,
investigations, audits, claims or other proceedings by or before a Governmental Authority.

“Affiliate” means, with respect to any Person, any other Person, directly or
indirectly through one or more intermediaries, controlling, controlled by or under common control
with such Person; provided, that for purposes of this Warrant, (a) the Issuer and its
Subsidiaries, on the one hand, shall not be deemed to be Affiliates of the Initial Holder, on the
other hand, and (b) the Major Stockholders, on the one hand, shall not be deemed to be Affiliates
of the Initial Holder or the Company, on the other hand. The term “control” (including,
with correlative meaning, the terms “controlled by” and “under common control
with”), as applied to any Person, means the possession, directly or indirectly, of the power to
direct or cause the direction of the management and policies of such Person, whether through the
ownership of voting or other securities, by contract or otherwise.

“BHC Act” means the Bank Holding Company Act of 1956, as amended, and the rules and
regulations promulgated thereunder, as in effect from time to time, and any other applicable
Federal banking law, regulation or policy.

“Board” means, as of any date, the Board of Directors of the Issuer in office on that
date.

“Business Day” means a day other than Saturday, Sunday or any other day on which banks
located in New York, New York are authorized or obligated by Law to close. If a payment date is
not a Business Day, payment may be made at such place on the next succeeding day that is a Business
Day, and no interest on the amount of such payment shall accrue for the intervening period.

“Certificate of Designation” means the form of Certificate of Designation of Series A
Convertible Non-Voting Preferred Stock attached hereto as Annex A.

“CIFC Parent” means CIFC Parent Holdings LLC, a Delaware limited liability company.

“Closing Price” with respect to any securities on any day means (a) the closing sale
price as of 4:00 p.m. Eastern Time on such day or any earlier final closing on such day or, if no
such sale takes place on such day, the average of the reported high and low bid prices on such day,
in each case on NASDAQ, or the New York Stock Exchange, as applicable, or, if such security is not
listed or admitted to trading on such national market or exchange, on the national stock exchange
or SEC-recognized trading market in the United States on which such security is quoted or listed or
admitted to trading, or, (b) if such securities are not quoted or listed or admitted to trading on
any national stock exchange or SEC-recognized trading market in the United States, the average of
the high and low bid prices of such security on the over-the-counter market on the day in question
as reported by the National Quotation Bureau Incorporated or a similar generally accepted reporting
service in the United States, or, if not so available, in such manner as furnished by any New York
Stock Exchange member firm selected from time to time by the Board for that purpose, or (c) if the
information in (a) and (b) is not available, a price determined in good faith by the Board, whose
determination shall be conclusive and described in a resolution of the Board.

“Common Stock” means the Common Stock, $0.001 par value per share, of the Issuer.

“Common Stock Record Date” means, with respect to any dividend, distribution or other
transaction or event in which the holders of Common Stock have the right to receive any cash,
securities or other property or in which the Common Stock (or other applicable security) is
exchanged for or converted into any combination of cash, securities or other property, (a) the date
fixed for determination of shareholders entitled to receive such cash, securities or other property
(whether such date is fixed by the Board or by statute, contract or otherwise), or (b) if different
from (a), the date on which the Common Stock trades “ex” the applicable dividend or distribution.

“Constituent Documents” means, with respect to any Person that is a corporation, its
articles or certificate of incorporation (for the avoidance of doubt, including any certificates of
designation with respect to capital stock of such Person), corporate charter or memorandum and
articles of association, as the case may be, and bylaws, with respect to any Person that is a
partnership, its certificate of partnership and partnership agreement, with respect to any Person
that is a limited liability company, its certificate of formation and limited liability company or
operating agreement, with respect to any Person that is a trust or other entity, its declaration or
agreement of trust or other constituent document, and with respect to any other Person, its
comparable organizational documents, in each case, as amended or restated.

“DFR Holdings” means DFR Holdings LLC, a Delaware limited liability company.

“Disposition Event” means (a) any merger or consolidation of the Issuer, or any sale
of the outstanding Shares or other transaction or series of related transactions (i) as a result of
which, in each such case, the holders of the Shares before such merger, consolidation or
transfer(s), together with their Affiliates, cease to hold, directly or indirectly, a majority of
the Shares or a majority of the outstanding voting securities of any successor to the Issuer
immediately following such merger, consolidation or transfer(s), and (ii) in which, in each such
case, the holders of the Shares before such merger, consolidation or transfer(s) receive cash (and
no other form of consideration) in consideration for their Shares; or (b) a Liquidation Event.

“Dispute” has the meaning assigned to such term in Section 14.12(a).

“Equity Interest” means any type of equity ownership in an entity, including
partnership interests in a general partnership or limited partnership, membership interests in a
limited liability company, stock or similar security (and any option, warrant, right or security,
including debt securities, convertible, exchangeable or exercisable thereto or therefor) in a
corporation or the comparable instruments for any other entity or any other interest entitling the
holder thereof to participate in the profits of such entity, the proceeds or the disposition of
such entity or any portion thereof or to vote for the governing body of such entity.

“Escalation Notice” has the meaning assigned to such term in Section 14.12(b).

“Exercise Notice” has the meaning assigned to such term in Section 2.01.

“Exercise Period” means any time after the Original Issuance Date but prior to the
Expiration Date.

“Exercise Price” has the meaning assigned to such term in the first paragraph of this
Warrant.

“Expiration Date” means September 24, 2014.

“GECC” means General Electric Capital Corporation, a Delaware corporation and the
indirect parent company of GECEI and GECDA.

“GECDA” means GE Capital Debt Advisors LLC, a Delaware limited liability company.

“GECEI” has the meaning assigned to such term in the first paragraph of this Warrant.

“Governmental Authority” means any foreign, federal, state or local governmental,
judicial, legislative, regulatory or administrative agency, commission or authority, and any court,
tribunal or arbitrator(s) of competent jurisdiction, including Self-Regulatory Organizations.

“Holder” or “Holders” means the registered holder or holders of this Warrant
or the registered holder or holders of certificates issued after the Original Issuance Date (in
addition to or in lieu of this Warrant) that represent this Warrant.

“include” and “including” shall be construed as if followed by the phrase “,
without being limited to,”.

“Initial Holder” has the meaning assigned to such term in the first paragraph of this
Warrant.

“Investment Agreement” means the Investment Agreement, dated as of the Original
Issuance Date, by and between the Issuer and GECEI, as the same may be modified and supplemented
and in effect from time to time.

“Issuer” has the meaning assigned to such term in the first paragraph of this Warrant.

“Law” means any statute, code, Order, law, ordinance, rule, regulation or other
requirement of any Governmental Authority (including, for the sake of clarity, common law).

“Lien” means any lien, pledge, encumbrance, mortgage, deed of trust, security
interest, equity, claim, lease, license, charge, option, adverse right, right of first or last
negotiation, offer or refusal, easement or transfer restriction of any kind or nature whatsoever,
whether arising by agreement, operation of Law or otherwise.

“Liquidation Event” means the voluntary or involuntary liquidation, dissolution or
winding up of the Issuer.

“Major Stockholders” means, together, DFR Holdings, CIFC Parent, and any Person that
is both a Stockholder and an Affiliate of either of the foregoing entities and any successors
thereto (each, a “Major Stockholder”).

“net issue exercise” means issuance of a number of Warrant Shares equal to (i) the
number of Shares for which the Warrant could then be exercised, multiplied by (ii) the
difference between the value of one share of Common Stock in the Disposition Event minus
the Exercise Price, then divided by (iii) the value of one share of Common Stock in the
Disposition Event.

“New York Court” has the meaning assigned to such term in Section 14.13(a).

“Order” means any judgment, order, injunction, stipulation, decree, writ, doctrine,
ruling, assessment or arbitration award or similar order of any Governmental Authority.

“Original Issuance Date” means September 24, 2012.

“Other Holder” means any Holder other than the Initial Holder. For the avoidance of
doubt, such term excludes any successor or registered assign of GECEI whose Equity Interests in the
Issuer must be aggregated with those of GECC for purposes of the BHC Act.

“Permitted Buyer” means any Person that is permitted under applicable Law and any
other international, federal, state, local, county or municipal governing regulations, ordinances,
rules, orders, compliance protocols, or statutes to own the Warrant Shares being purchased from a
Holder following exercise of the Warrant.

“Person” means any individual, corporation, partnership, limited liability company,
limited liability partnership, firm, joint venture, association, joint-stock company, trust,
unincorporated organization, Governmental Authority or other entity.

“Preferred Stock” means the Series A Convertible Non-Voting Preferred Stock, par value
$0.001 per share, of the Issuer, each share of which shall have the designations, powers,
preferences and rights, and the qualifications, limitations or restrictions thereof, set forth in
the Certificate of Designation. Such designations, powers, preferences and rights shall include
that the Preferred Stock shall be mandatorily exchanged for Common Stock on a share-for-share basis
if transferred to any Other Holder.

“Purchase Agreement” means the Asset Purchase Agreement, dated as of July 30, 2012, by
and among the Issuer, GECDA, and GECC, as the same may be amended, modified, supplemented or
restated from time to time.

“Redeemable Capital Stock” has the meaning assigned to such term in Section
4.07.

“Redemption Event” has the meaning assigned to such term in Section 4.08.

“Registration Rights Agreement” means the Second Amended and Restated Registration
Rights Agreement, dated as of the Original Issuance Date, by and among the Issuer, GECEI, DFR
Holdings, and CIFC Parent, as the same may be modified and supplemented and in effect from time to
time.

“SEC” means the United States Securities and Exchange Commission or any successor
entity thereto.

“Securities Act” means the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder, as in effect from time to time.

“Self-Regulatory Organization” means each national securities exchange in the United
States of America or other commission, board, agency or body that is charged with the supervision
or regulation of brokers, dealers, securities underwriting or trading, stock exchanges, commodities
exchanges, insurance companies or agents, investment companies or investment advisers, or to the
jurisdiction of which any Party or any of their respective Subsidiaries is otherwise subject.

“Shares” means, collectively (but without duplication), (a) shares of Common Stock,
(b) shares of Preferred Stock, or (c) shares of other classes or series of capital stock of the
Issuer that may exist from time to time.

“Stockholders” means the holders of Shares from time to time and “Stockholder”
means any one of them.

“Subsidiary” means, with respect to any Person, a corporation or other Person of which
more than fifty percent (50%) of the voting power of the outstanding voting Equity Interests or
more than fifty percent (50%) of the outstanding economic Equity Interest is held, directly or
indirectly, by such Person.

“Voting Shares” means any outstanding Shares, including the Common Stock, that, as of
the applicable determination date, are entitled to vote on matters submitted to a vote at a meeting
of Stockholders.

“Warrant” and “Warrants” have the respective meanings set forth in the second
paragraph of this Warrant.

“Warrant Shares” means, collectively (but without duplication), (a) the Shares
issuable upon exercise of this Warrant in accordance with its terms, (b) any securities into which
or for which such Shares shall have been converted or exchanged pursuant to any recapitalization,
reorganization or merger of the Issuer, and (c) any securities issued with respect to the foregoing
pursuant to a dividend, distribution or split.

SECTION 2. Exercise of Warrant.

2.01 Mechanics of Exercise. Subject to all of the terms and conditions hereof, during the
Exercise Period, a Holder may exercise this Warrant, on one or more occasions, on any Business Day
(or any other day on which a Disposition Event occurs), in whole or in part, by delivering to the
Issuer, at its office maintained for such purpose pursuant to Section 14.01 hereof, (a) a
written notice of the Holder’s election to exercise this Warrant substantially in the form attached
hereto as Annex B, which notice shall specify the number of Warrant Shares to be purchased
(the “Exercise Notice”), (b) a check or checks payable to the Issuer (or by any other
reasonable acceptable form of immediately available funds including by wire transfer) in an
aggregate amount equal to the aggregate Exercise Price for the number of Warrant Shares as to which
this Warrant is being exercised, (c) this Warrant, and (d) to the extent the Holder is an Affiliate
of GECEI and not a party to the Investment Agreement, a “statement of adhesion” pursuant to which
such Affiliate confirms its agreement to be subject to and bound by all of the provisions set forth
in the Investment Agreement that are applicable to Investor Holders (as defined in the Investment
Agreement).

2.02 Automatic Exercise. If at any time during the Exercise Period, the Issuer effects a
Disposition Event, then this Warrant shall automatically (without any act on the part of the
Holder) be exercised pursuant to this Section 2.02, effective immediately prior to the
consummation of such Disposition Event on a net issue exercise basis to the extent such net issue
exercise would result in the issuance of Warrant Shares; provided, that if such net issue
exercise would not result in the issuance of Warrant Shares upon the consummation of such
Disposition Event, this Warrant shall thereafter be cancelled and be of no further force and
effect; provided, further, that in the case of a Disposition Event structured as a
merger or consolidation of the Issuer, the Warrant shall be redeemed or cancelled in exchange for a
payment of the applicable cash payable to holders of the number of Shares for which the Warrant
could then be exercised minus the aggregate Exercise Price; provided, further, that
in the case of a Disposition Event structured as a sale of Voting Shares, the Issuer shall use
commercially reasonable efforts to make such provisions as are necessary to ensure that the Holder
will be given the option of selling the Warrant. If this Warrant is automatically exercised
pursuant to this Section 2.02, the Issuer shall notify the Holder of the automatic exercise
as soon as reasonably practicable, and the Holder shall surrender the Warrant to the Issuer in
accordance with the terms hereof.

2.03 Certificates. Upon receipt of an Exercise Notice, the Issuer shall, as promptly as
practicable and in any event within twenty (20) Business Days thereafter, execute or cause to be
executed and deliver or cause to be delivered to the Holder a stock certificate or certificates
representing the aggregate number of Warrant Shares and other securities issuable upon such
exercise. The stock certificate or certificates for Warrant Shares or other securities so
delivered shall be in such denominations as may be specified in the Exercise Notice (subject always
to Section 12.02 hereto) and shall be registered in the name of the Holder or, subject to
Section 14.03 hereof, such other name or names as shall be designated in such Exercise
Notice. Except as prohibited by applicable Law, such stock certificate or certificates shall be
deemed to have been issued and the Holder or any other Person so designated to be named therein
shall be deemed to have become a holder of record of such shares, including, to the extent
permitted by Law, the right to vote such shares (with respect to Voting Shares) or to consent or to
receive notice as a stockholder, as of the date on which the Issuer receives the last of the
Exercise Notice, payment of the Exercise Price and this Warrant as aforesaid, and all taxes
required to be paid by the Holder prior to the issuance of such shares pursuant to Section
9 hereof, if any, have been paid. If this Warrant shall have been exercised only in part, the
Issuer shall, at the time of delivery of the certificate or certificates representing Warrant
Shares and other securities, execute and deliver to the Holder a new warrant certificate evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares provided for in this Warrant,
which new warrant certificate shall in all other respects be identical with this Warrant, or, at
the request of the Holder, appropriate notation may be made on this Warrant and the same returned
to the Holder. The Issuer agrees that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of executing stock certificates to execute and issue
the necessary certificates for Warrant Shares.

2.04 Representations and Warranties. All Warrant Shares shall, upon payment therefor in
accordance with Section 2.01, be duly and validly issued, fully paid and nonassessable and
free and clear of any Liens, other than (a) those Liens created by the Holder thereof, (b)
restrictions under United States federal and state securities laws, and (c) with respect to the
Initial Holder, any restrictions under the Investment Agreement.

2.05 Fractional Shares. The Issuer shall not be required to issue a fractional Warrant
Share upon exercise of this Warrant. As to any fraction of a share that a Holder would otherwise
be entitled to purchase upon such exercise, the Holders shall be entitled to a cash adjustment in
respect of such final fraction in an amount equal to the same fraction of the Closing Price per
share of Common Stock on the Business Day immediately preceding the date of exercise, which cash
adjustment may be paid by netting it from the aggregate Exercise Price payable upon such exercise
of this Warrant or by payment from the Issuer.

2.06 Regulatory Matters. Except in the case of a net issuance pursuant to Section
2.02, exercise of the Warrant is subject to the condition that the Holder (or such other Person
or Persons named in the Exercise Notice) is permitted to own the Warrant Shares under applicable
Law.

SECTION 3. Transfer, Division and Combination. Subject to Section 14.03 hereof,
transfer of this Warrant and all rights hereunder, in whole or in part, shall be registered on the
books of the Issuer to be maintained for such purpose, upon surrender of this Warrant at the office
of the Issuer maintained for such purpose pursuant to Section 14.01 hereof, together with a
written assignment of this Warrant, substantially in the form of Annex C hereto, duly
executed by the Holder or its agent or attorney and payment of funds sufficient to pay any transfer
taxes payable upon the making of such transfer. Upon such surrender and, if required, such
payment, the Issuer shall, subject to Section 14.03 hereof and the immediately following
sentence, (a) execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees and in the denominations specified in such instrument of assignment, (b) issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned and (c) promptly
cancel this Warrant. This Warrant, if properly transferred in compliance with this Section
3 and Section 14.03 hereof, may be exercised by a transferee, if permitted by the terms
hereof, for the purchase of Warrant Shares without having a new Warrant or Warrants issued.
Notwithstanding any provision herein to the contrary, the Issuer shall not be required to register
the transfer of Warrants or Warrant Shares in the name of any Person who acquired this Warrant (or
part hereof) or any Warrant Shares otherwise than in compliance with all applicable restrictions in
this Warrant. The Issuer shall maintain at its aforesaid office books for the registration and
transfer of the Warrants.

SECTION 4. Adjustments to Exercise Price and Number of Warrant Shares Issuable Upon Warrant
Exercise. The Exercise Price and the number of Warrant Shares issuable upon exercise hereof
shall be subject to adjustment from time to time as set forth in this Section 4.
Notwithstanding anything in this Section 4 to the contrary, in no event shall the Exercise
Price be reduced below the par value of a Warrant Share.

4.01 Dividend or Distribution of Common Stock. If the Issuer shall hereafter pay a
dividend or make a distribution to all holders of the outstanding shares of Common Stock in shares
of Common Stock, the Exercise Price in effect at the opening of business on the date following the
Common Stock Record Date shall be reduced by multiplying such Exercise Price by a fraction, (a) the
numerator of which shall be the number of shares of Common Stock outstanding at the close of
business on the Common Stock Record Date and (b) the denominator of which shall be the sum of such
number of shares and the total number of shares constituting such dividend or other distribution,
such reduction to become effective immediately after the opening of business on the day following
the Common Stock Record Date. If any dividend or distribution of the type described in this
Section 4.01 is declared but not so paid or made, the Exercise Price shall again be
adjusted to the Exercise Price which would then be in effect if such dividend or distribution had
not been declared.

4.02 Stock Splits and Reverse Stock Splits. If the outstanding shares of Common Stock
shall be subdivided into a greater number of shares of Common Stock, the Exercise Price in effect
at the opening of business on the day following the day upon which such subdivision becomes
effective shall be proportionately reduced, and, conversely, if the outstanding shares of Common
Stock shall be combined into a smaller number of shares of Common Stock, the Exercise Price in
effect at the opening of business on the day following the day upon which such combination becomes
effective shall be proportionately increased, such reduction or increase, as the case may be, to
become effective immediately after the opening of business on the day following the day upon which
such subdivision or combination becomes effective.

4.03 Other In-Kind Distributions. If the Issuer shall, by dividend or otherwise,
distribute to all holders of its shares of Common Stock any class of capital stock of the Issuer
(other than any dividends or distributions to which Section 4.01 applies) or evidences of
its indebtedness, cash, securities or other assets (excluding any capital stock, evidences of
indebtedness, cash or assets distributed upon a merger or consolidation to which Section
5.01 applies), then, in each such case, the Issuer shall make proper provision so that a Holder
who exercises this Warrant (or any portion thereof) after the applicable Common Stock Record Date
(including any automatic exercise pursuant to Section 2.02 hereunder) shall be entitled to
receive upon such exercise or purchase or automatic exercise, in addition to the Warrant Shares
issuable upon such exercise, the amount and kind of such distribution that such Holder would have
been entitled to receive if such Holder had, immediately prior to such Common Stock Record Date,
exercised this Warrant.

4.04 Deferral. In any case in which this Section 4 provides that an adjustment
shall become effective immediately after a Common Stock Record Date for an event, the Issuer may
defer until the occurrence of such event issuing to the Holder of any Warrant exercised after such
Common Stock Record Date and before the occurrence of such event the additional shares of Common
Stock issuable upon such exercise by reason of the adjustment required by such event over and above
the shares of Common Stock issuable upon such exercise before giving effect to such adjustment.

4.05 Treasury Shares. For purposes of this Section 4, the number of shares of
Common Stock at any time outstanding shall not include shares held in the treasury of the Issuer or
by any of its Subsidiaries. The Issuer shall not pay any dividend or make any distribution on
shares of Common Stock held in the treasury of the Issuer or by any of its Subsidiaries.

4.06 Adjustment of Warrant Shares Issuable. Upon each adjustment of the Exercise Price as
a result of the operation of this Section 4, this Warrant shall thereafter evidence the
right to purchase, at the adjusted Exercise Price, that number of Warrant Shares obtained by
multiplying the number of shares covered by this Warrant immediately prior to this adjustment by
the Exercise Price in effect immediately prior to such adjustment and dividing the product so
obtained by the Exercise Price in effect immediately after such adjustment of the Exercise Price.

4.07 Redeemable Capital Stock. In the event that a Holder would be entitled to receive
upon exercise hereof any Redeemable Capital Stock (as defined below) and the Issuer redeems,
exchanges or otherwise acquires all of the outstanding shares or other units of such Redeemable
Capital Stock (such event being a “Redemption Event”), then, from and after the effective
date of such Redemption Event, the Holder shall be entitled to receive upon exercise, in lieu of
shares or units of such Redeemable Capital Stock, the kind and amount of shares of stock and other
securities and property receivable upon the Redemption Event by a holder of the number of shares or
units of such Redeemable Capital Stock for which this Warrant could have been exercised immediately
prior to the effective date of such Redemption Event (assuming, to the extent applicable, that such
holder failed to exercise any rights of election with respect thereto and received per share or
unit of such Redeemable Capital Stock the kind and amount of stock and other securities and
property received per share or unit by a plurality of the non-electing shares or units of such
Redeemable Capital Stock), and (from and after the effective date of such Redemption Event) the
Holder shall have no other purchase rights under this Warrant with respect to such Redeemable
Capital Stock. For purposes of this Section 4.07, “Redeemable Capital Stock” means
a class or series of capital stock of the Issuer that provides by its terms a right in favor of the
Issuer to call, redeem, exchange or otherwise acquire all of the outstanding shares or units of
such class or series.

SECTION 5. Consolidation, Merger, Share Exchange, etc.; Reclassification or
Recapitalization.

5.01 Consolidation, Merger, Share Exchange, etc. In case a consolidation, merger or share
exchange of the Issuer shall be effected with another Person on or after the Original Issuance
Date, then, as a condition of such consolidation, merger or share exchange, lawful and adequate
provision shall be made whereby the Holder(s) shall thereafter have the right to purchase and
receive, upon the basis and upon the terms and conditions specified herein and in lieu of each
Warrant Share immediately theretofore purchasable and receivable upon the exercise of the Warrant,
such shares of stock or other Equity Interests, securities, cash or other property that would have
been received upon such consolidation, merger or share exchange by the holder of a share of Common
Stock immediately prior to such event. The Issuer shall not effect any such consolidation, merger
or share exchange unless, prior to or simultaneously with the consummation thereof, the successor
Person (if other than the Issuer) resulting from such consolidation, merger or share exchange,
shall assume, by written instrument, the obligation to deliver to the Holder(s) such shares of
stock, securities, cash or other property as, in accordance with the foregoing provisions, such
Holder(s) may be entitled to purchase upon the exercise of the Warrant. The above provisions of
this Section 5.01 shall similarly apply to successive consolidations, mergers or share
exchanges.

5.02 Reclassification or Recapitalization. If the Warrant Shares issuable upon exercise of
this Warrant are changed into the same or a different number of shares of any class or classes or
series of stock of the Issuer or other securities or property of the Issuer, whether by
reorganization, recapitalization, reclassification or otherwise (other than a subdivision or
combination of Shares or stock dividend provided for in Section 4 or a consolidation,
merger or share exchange provided for in Section 5.01), then from and after each such
event, subject to Section 12.02, the Holder(s) shall have the right to exercise the Warrant
for the amount and kind of shares of stock and other securities and property receivable upon such
reorganization, recapitalization, reclassification or other change by a holder of the number of
Warrant Shares for which this Warrant would have been exercisable immediately prior to such
reorganization, recapitalization, reclassification or change, subject to further adjustment as
provided herein.

SECTION 6. Notice to Holder.

6.01 Notice of Events Under Sections 4 or 5. Whenever the number of Warrant Shares
issuable upon exercise hereof or the Exercise Price shall be adjusted pursuant to Section 4
or otherwise changed pursuant to Section 5 hereof, the Issuer shall forthwith obtain a
certificate signed by an officer or the controller of the Issuer, setting forth, in reasonable
detail, the event requiring the adjustment or change and the method by which such adjustment or
change was calculated and specifying the adjusted Exercise Price and total number of Warrant Shares
(or other securities) issuable upon exercise of the Warrant, as adjusted or changed. Upon request
of any Holder, the Issuer shall promptly, and in any case within ten (10) days after the making of
such request, cause a signed copy of such certificate to be delivered to such Holder in accordance
with Section 14.02 hereof. The Issuer shall keep at its office or agency, maintained for
the purposes set forth in Section 14.01 hereof, copies of all such certificates and cause
the same to be available for inspection at said office during normal business hours by any Holder
or any prospective Permitted Buyer of a Warrant designated by a Holder. Failure to deliver any
notice pursuant to this Section shall not affect the legality or validity of any adjustment or
change that was to be the subject of such notice.

6.02 Notice of Certain Corporate Actions. In case the Issuer shall propose to (a) pay any
dividend to the holders of its Shares or to make any other distribution to the holders of its
Shares (other than stock dividends of Shares), (b) offer to the holders of its Shares rights to
subscribe for or to purchase any Shares or shares of stock of any class or any other securities or
options, warrants or other rights to purchase any securities, (c) effect any reclassification of
its Shares (other than a reclassification involving only the subdivision, or combination, of
outstanding Shares), (d) effect any capital reorganization, (e) effect a Liquidation Event (or if
the Board approves any Liquidation Event), (f) effect any registration of Shares under the
Securities Act (whether for the account of the Issuer or for the account of any of its
stockholders), (g) effect any Disposition Event (other than a Liquidation Event), or (h) take any
action referred to in Sections 4 or 5, then, in each such case, the Issuer shall give to
each Holder, in accordance with Section 14.02 hereof, a notice of such proposed action, to
the extent, and at substantially the same time and provide substantially the same information as,
provided to the holders of Common Stock in connection therewith.

SECTION 7. Reservation and Authorization of Warrant Shares.

7.01 Reservation of Warrant Shares. The Issuer shall at all times reserve and keep
available for issue upon the exercise or conversion of the Warrants such number of its authorized
but unissued (a) shares of Common Stock and (b) shares of Preferred Stock, in each case, as will be
sufficient to permit the exercise in full of all outstanding Warrants pursuant to the terms of this
Warrant, including Section 12.02 and any adjustment to the number of Warrant Shares
issuable hereunder pursuant to Section 4.07 of this Warrant, and for the exchange of shares
of Preferred Stock for shares of Common Stock, and, from time to time, will take all steps
necessary to amend its Constituent Documents or pass resolutions to provide sufficient reserves of
Warrant Shares.

7.02 Corporate Authorization of Adjustments. Before or concurrently with taking any action
that would result in an adjustment to the Exercise Price, the Issuer shall take any corporate
action that is necessary in order that the Issuer may validly and legally issue fully paid and
nonassessable shares of Common Stock or Preferred Stock free and clear of any Liens, other than (a)
those Liens created by the Holder thereof, (b) restrictions under United States federal and state
securities laws, and (c) with respect to the Initial Holder, any restrictions under the Investment
Agreement, upon the exercise of all of the Warrants immediately after the taking of such action.

SECTION 8. Reserved.

SECTION 9. Expenses, Transfer Taxes and Other Charges. The Issuer shall pay any and all
expenses, transfer taxes and other charges, including all costs associated with the preparation,
issue and delivery of stock or warrant certificates, that are incurred in respect of the issuance
or delivery of shares of Common Stock or Preferred Stock, as applicable, upon exercise of this
Warrant pursuant to Section 2 and Section 12.02 hereof, or in connection with any
division or combination of Warrants pursuant to Sections 3, 4 or 5 hereof. The Issuer
shall not, however, be required to pay any tax which may be payable in respect of (a) the income,
franchise or capital gain of any Holder, (b) any transfer involved in the issue and delivery of
Warrant Shares in a name other than that in which this Warrant is registered, and no such issue or
delivery shall be made unless and until the Person requesting such issue has paid to the Issuer the
amount of any such tax, or has established, to the satisfaction of the Issuer, that such tax has
been paid or (c) any transfer of the Warrant, and no transfer shall be made unless and until the
Person requesting such transfer has been paid to the Issuer the amount of any such tax, or has
established, to the satisfaction of the Issuer, that such tax has been paid.

SECTION 10. No Impairment. The Issuer will not, by amendment of its Constituent Documents
or through any reorganization, transfer of assets, consolidation, merger, dissolution, or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in
the taking of all such action as may be necessary or appropriate in order to protect the rights of
the Holder(s) of this Warrant against impairment. Without limiting the generality of the
foregoing, the Issuer (i) will not increase the par value of any Shares receivable on the exercise
of this Warrant above the amount payable therefor on such exercise, and (ii) will take all such
action as may be necessary or appropriate in order that the Issuer may validly and legally issue
fully paid and non-assessable Shares on the exercise of this Warrant.

SECTION 11. Registration Rights. Following exercise of this Warrant, the Holder(s) will
have certain rights relating to the registration of the shares of Common Stock issued upon exercise
hereof at the times and in the manner specified in the Registration Rights Agreement.

SECTION 12. No Voting Rights.

12.01 No Holder by virtue of this Warrant shall be entitled to any voting or other rights as
a stockholder of the Issuer or to be deemed the holder of Common Stock, nor shall anything
contained herein be construed to confer upon any Holder any of the rights of a stockholder of the
Issuer or any right to vote for the election of directors or upon any matter submitted to
stockholders at any meeting thereof, or to give or withhold consent to any corporate action
(whether upon any recapitalization, issuance or reclassification of shares, change of par value or
change of shares to no par value, consolidation, merger or conveyance or otherwise), or to receive
notice of meetings or to receive subscription rights, except to the extent otherwise provided in
this Warrant and this Section 12.

12.02 Notwithstanding anything to the contrary in this Warrant or in any Exercise Notice
delivered under Section 2.01, the Warrant Shares issuable upon exercise of this Warrant in
accordance with Section 2.01 shall be as follows:

(a) Common Stock shall be issuable in connection with any exercise of this Warrant by any
Other Holder;

(b) Except as set forth in Section 12.02(a), only Preferred Stock shall be issuable in
connection with any other exercise of this Warrant.

	 	 	 	 	 
	 	 	SECTION 13.

	 	Reserved.
	 	 	
 
	 	 
	SECTION 14.
	 	Miscellaneous.

	 	

	 	 	 

	 	

14.01 Office of Issuer. So long as any of the Warrants remain outstanding, the Issuer
shall maintain an office in the continental United States of America where the Warrants may be
presented for exercise, transfer, division or combination as in this Warrant provided. Such office
shall be at 250 Park Avenue, 4th Floor, New York, NY 10177, unless and until the Issuer shall
designate and maintain some other office for such purposes and give notice thereof to all Holders.

14.02 Notices Generally. Any notices and other communications pursuant to the provisions
hereof shall be sent in accordance with Section 9.2 of the Purchase Agreement.

14.03 Transferability. The Initial Holder may transfer this Warrant at any time, in whole
or in part, without the consent of the Issuer, (a) to any Affiliate of GECC, or (b) to any Person
that is not an Affiliate of GECC; provided that any transfer under this Section
14.03(b) is made in compliance with the Securities Act and Section 3.

14.04 Amendments and Waivers. Any term of this Warrant may be amended and the observance
of any terms of this Warrant may be waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Issuer and the Holders at the
time thereof.

14.05 Headings. The headings contained in this Warrant are for reference purposes only and
shall not affect in any way the meaning or interpretation of this Warrant.

14.06 Severability. If any provision of this Warrant, or the application thereof to any
person or circumstance, is invalid or unenforceable in any jurisdiction: (a) a substitute and
equitable provision shall be substituted therefor in order to carry out, so far as may be valid and
enforceable in such jurisdiction, the intent and purpose of their invalid or unenforceable
provision; and (b) the remainder of this Warrant and the application of such provision to other
persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall
such invalidity or unenforceability of such provision affect the validity or enforceability of such
provision, or the application thereof, in any other jurisdiction.

14.07 Governing Law; Waiver of Jury Trial. THIS WARRANT (AND ANY CLAIMS OR DISPUTES
ARISING OUT OF OR RELATED HERETO OR TO THE TRANSACTIONS CONTEMPLATED HEREBY OR TO THE INDUCEMENT OF
ANY PARTY TO ENTER HEREIN, WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE AND
WHETHER PREDICATED ON COMMON LAW, STATUTE OR OTHERWISE) SHALL IN ALL RESPECTS BE GOVERNED BY AND
CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT
REFERENCE TO ITS CHOICE OF LAW RULES THAT WOULD APPLY THE LAWS OF ANY OTHER JURISDICTION. THE
PARTIES HERETO EACH HEREBY WAIVE TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR
INDIRECTLY, ANY MATTERS (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT
OF, RELATED TO OR CONNECTED WITH THIS WARRANT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

14.08 Limitation of Liability. No provision hereof, in the absence of affirmative action
by the Holder to purchase Warrant Shares, and no mere enumeration herein of the rights or
privileges of the Holder, shall give rise to any liability of the Holder for the Exercise Price or
as a stockholder of the Issuer, whether such liability is asserted by the Issuer, by any creditor
of the Issuer or any other Person.

14.09 Replacement. On receipt of evidence reasonably satisfactory to the Issuer of the
loss, theft, destruction, or mutilation of this Warrant and, in the case of loss, theft, or
destruction, on delivery of any indemnity agreement or bond reasonably satisfactory in form and
amount to the Issuer or, in the case of mutilation, on surrender and cancellation of this Warrant,
the Issuer at its expense will execute and deliver, in lieu of this Warrant, a new Warrant of like
tenor.

14.10 Binding Effect. This Warrant shall inure to the benefit of and be binding upon the
parties hereto and their respective successors and permitted assigns. Nothing in this Warrant is
intended or shall be construed to confer upon any person other than the parties hereto.

14.11 Remedies. In the event of a breach of this Warrant, the Holder shall be entitled to
injunctive relief and specific performance of its rights under this Warrant, in addition to all of
its rights granted by Law, including recovery of damages. The Issuer agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach of this Warrant by
the Issuer and hereby waives any defense in any action for injunctive relief or specific
performance that a remedy at Law would be adequate.

14.12 Dispute Resolution.

(a) Except with respect to any request for equitable relief (including interim relief), any
dispute, controversy or claim arising out of or relating to the transactions contemplated by this
Warrant, or the validity, interpretation, breach or termination of this Warrant, including claims
seeking redress or asserting rights under any Law (a “Dispute”), shall be resolved in
accordance with the procedures set forth in this Section 14.12. Until completion of such
procedures, no party may take any action to force a resolution of a Dispute by any judicial or
similar process, except to the limited extent necessary to (i) avoid expiration of a claim that
might eventually be permitted by this Warrant or (ii) obtain equitable relief; provided,
that the rights reserved in clause (i) of Section 14.12(a) may be exercised within three
(3) months prior to the expiration of the applicable claim.

(b) Any party hereto seeking resolution of a Dispute shall first serve on the other a notice
(an “Escalation Notice”) specifying the details of the relevant Dispute and requiring that
such Dispute be referred to the parties’ representatives set out in Schedule 5.2(b) of the
Investment Agreement. In the event that such parties’ representatives are unable to resolve such
disagreement within fifteen (15) Business Days following the Escalation Notice, either party hereto
may submit the Dispute for resolution by mediation pursuant to the International Institute for
Conflict Prevention & Resolution Mediation Procedure as then in effect. Mediation will continue
for at least thirty (30) days from the date such mediation was commenced, unless the mediator
chooses to withdraw sooner.

(c) All offers of compromise or settlement among the parties in connection with the attempted
resolution of any Dispute shall be deemed to have been delivered in furtherance of a Dispute
settlement and shall be exempt from discovery and production and shall not be admissible in
evidence (whether as an admission or otherwise) in any proceeding for the resolution of the
Dispute.

(d) For the avoidance of doubt, the parties hereto agree that either of them may seek interim
measures including injunctive relief in relation to the provisions of this Warrant or the parties’
performance of it from any New York Court.

14.13 Jurisdiction.

(a) Each of the parties hereto agrees that if any Dispute is not resolved pursuant to the
procedures set forth in Section 14.12, such Dispute shall be resolved only in the State
Courts of the State of New York, New York County or the United States District Court located in the
State of New York, New York County (the “New York Courts,” and each, a “New York Court”).
In that context, and without limiting the generality of the foregoing, each of the parties hereto
by this Warrant irrevocably and unconditionally:

(b) submits for itself and its property in any Action relating to this Warrant or for
recognition and enforcement of any judgment in respect thereof, to the exclusive jurisdiction of
the New York Courts, and agrees that all claims in respect of any such Action shall be heard and
determined in the New York Courts;

(c) consents that any such Action may and shall be brought in the New York Courts and waives
any objection that it may now or hereafter have to the venue or jurisdiction of any such Action in
the New York Courts or that such Action was brought in an inconvenient court and agrees not to
plead or claim the same;

(d) agrees that service of process in any such Action may be effected by mailing a copy of
such process by registered or certified mail (or any substantially similar form of mail), postage
prepaid, to such party at its address as provided in Section 14.02; and

(e) agrees that nothing in this Agreement shall affect the right to effect service of process
in any other manner permitted by the Laws of the State of New York.

14.14 Counterparts. This Warrant may be executed in counterparts (including by facsimile
or other electronic transmission), each of which shall be deemed an original and each of which
shall constitute one and the same instrument.

[Signature page follows]

IN WITNESS WHEREOF, the Issuer has duly executed this Warrant.

	 	 	 
	 	 	CIFC CORP.
	 
	 	By:  /s/ Peter Gleysteen

	 	 	 

	 	 	Name: Peter Gleysteen

Title: Chief Executive Officer

	 	 	 

	      
	 	GE CAPITAL EQUITY INVESTMENTS, INC.

	 	 	By:        

	 	 	 

	 	 	Name:

	 	 	Title:

1

ANNEX A

to

Warrant

FORM OF CERTIFICATE OF DESIGNATION

CIFC CORP.

CERTIFICATE OF DESIGNATION OF

SERIES A CONVERTIBLE NON-VOTING PREFERRED STOCK

The undersigned, Robert C. Milton, III, the Secretary of CIFC Corp., a corporation organized
and existing under the laws of the State of Delaware (the “Corporation”), does hereby
certify that the following resolutions were duly adopted by the Board of Directors of the
Corporation (the “Board of Directors”) on July 30, 2012 pursuant to Section 151(g) of the
Delaware General Corporation Law (“DGCL”) and in accordance with the provisions of its
Certificate of Incorporation, as amended, restated or otherwise modified through the date hereof
(the “Certificate of Incorporation”):

WHEREAS, the Board of Directors may issue shares of the Corporation’s preferred stock, par
value $0.001 per share (the “Preferred Stock”), from time to time in one or more series
pursuant to a resolution or resolutions providing for such issue duly adopted by the Board of
Directors (authority to do so being hereby expressly vested in the Board of Directors);

WHEREAS, the Board of Directors is further authorized, subject to limitations prescribed by
law, to fix by resolution or resolutions the designations, powers, preferences and rights, and the
qualifications, limitations or restrictions thereof, of any wholly unissued series of Preferred
Stock, including without limitation authority to fix by resolution or resolutions the dividend
rights, dividend rate, conversion rights, voting rights, rights and terms of redemption (including
sinking fund provisions), redemption price or prices, and liquidation preferences of any such
series, and the number of shares constituting any such series and the designation thereof, or any
of the foregoing; and

WHEREAS, it is the desire of the Board of Directors, pursuant to its authority as aforesaid,
to authorize and fix the terms of a series of Preferred Stock and the number of shares constituting
such series.

NOW, THEREFORE, BE IT RESOLVED:

Section 1. Designation, Amount and Par Value. A series of Preferred Stock, designated
the “Series A Convertible Non-Voting Preferred Stock” (“Series A Preferred Stock”), is hereby
established. The number of shares of Series A Preferred Stock that the Corporation has the
authority to issue is 2,000,000. Each such share shall have a par value of $0.001. The
Corporation shall not issue any shares of Series A Preferred Stock, except pursuant to (and in
accordance with the terms of) the Warrant to Purchase Common Stock or Preferred Stock issued by the
Corporation to GE Capital Equity Investments, Inc. on or about September 24, 2012 (the “Warrant”).

Section 2. Rank. The Series A Preferred Stock shall in all respects, including with
respect to dividend rights and rights upon liquidation, dissolution or the winding up of the
Corporation, rank on parity with all classes or series of shares of common stock, par value $0.001
per share, of the Corporation (“Common Stock”).

Section 3. Dividends. Dividends and other distributions (including, without
limitation, (x) any grant or distribution of rights to subscribe for or purchase shares of capital
stock or securities or indebtedness convertible into capital stock of the Corporation or (y) any
redemption effected pro rata among all holders of Common Stock), payable in cash, securities or
other property, shall be payable on Series A Preferred Stock equally, ratably and on a parity with
such dividends and other distributions payable on Common Stock, as and when such dividends and
other distributions are declared by the Board of Directors, as though Common Stock and Series A
Preferred Stock were one and the same class; provided, that if (a) the dividends consist of Common
Stock, the Corporation shall make available to each holder of Series A Preferred Stock dividends
consisting of Series A Preferred Stock and (b) the dividends consist of voting securities of the
Corporation other than Common Stock, the Corporation shall make available to each holder of Series
A Preferred Stock dividends consisting of non-voting securities of the Corporation that are
otherwise identical to such voting securities and that are convertible or exchangeable for such
voting securities on the substantially similar terms as the Series A Preferred Stock is convertible
into Common Stock; and provided, further, that unless the corresponding dividend or other
distribution on the Series A Preferred Stock described in this Section 3 is declared, paid or set
aside for payment concurrently with the dividend or other distribution on the Common Stock, the
Corporation shall not declare, pay or set aside for payment any dividend or distribution on the
Common Stock (including, without limitation, (x) any grant or distribution of rights to subscribe
for or purchase shares of capital stock or securities or indebtedness convertible into capital
stock of the Corporation or (y) any redemption effected pro rata among all holders of Common
Stock). Without limiting the generality of the foregoing, if the outstanding shares of Common
Stock are split or subdivided into a greater number of shares of Common Stock, the Corporation
shall declare a corresponding split or subdivision on the Series A Preferred Stock. If the
outstanding shares of Common Stock are combined into a smaller number of shares of Common Stock,
the Company shall combine the Series A Preferred Stock accordingly.

Section 4. Voting Rights. The holders of Series A Preferred Stock shall not have the
right to vote for the election of directors or for any other purpose, except as set forth in this
Section 4. With respect to all matters the holders of Series A Preferred Stock are entitled to
vote on, each holder of Series A Preferred Stock shall be entitled to one vote per share. With
respect to any vote set forth in this Section 4, each share of Series A Preferred Stock shall
entitle the holder thereof to cast that number of votes as is equal to the number of votes that
such holder would be entitled to cast had such shares of Series A Preferred Stock converted into
shares of Common Stock pursuant to Section 5 on the record date for determining the stockholders of
the Corporation eligible to vote on any such matters.

4.1 So long as any shares of the Series A Preferred Stock are outstanding, the
Corporation shall not, without the affirmative vote of the holders of a majority of the then
outstanding shares of Series A Preferred Stock, approve any amendment, alteration or repeal
(including, without limitation, by way of merger, consolidation, operation of law, or otherwise) of
any provision of this Certificate of Designation or the Certificate of Incorporation that would (i)
increase or decrease the par value per share of Series A Preferred Stock or (ii) alter or change
the powers, preferences or special rights of the shares of Series A Preferred Stock so as to affect
them adversely; or

4.2 Except as provided in Section 4.3 below, so long as any shares of the Series A
Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the
holders of a majority of the outstanding shares of Series A Preferred Stock, increase or decrease
the aggregate number of authorized shares of Series A Preferred Stock.

4.3 Notwithstanding anything in 242(b)(2) of the DGCL or Section 4.2 to the
contrary, (a) in the event that the number of shares of Series A Preferred issuable pursuant to the
Warrant exceeds the number of shares of Series A Preferred Stock that are then authorized but not
outstanding, the Corporation shall by resolution adopted in accordance with Section 151(g) of the
DGCL increase the number of authorized shares of Series A Preferred Stock to a number equal to the
total number of shares of Series A Preferred Stock then outstanding plus the total number of shares
of Series A Preferred Stock then issuable upon exercise of the Warrant (a “Mandatory Increase”) and
(b) the affirmative vote of the holders of a majority of the outstanding shares of Series A
Preferred Stock shall not be required to effect such Mandatory Increase.

Section 5. Conversion.

5.1 Shares of Series A Preferred Stock shall not be convertible into shares of
Common Stock, except upon any transfer of any shares of Series A Preferred Stock to any Person that
is a Non-GE Holder. Each share of Series A Preferred Stock transferred to any Non-GE Holder shall
automatically convert, upon such transfer and without any further action on the part of any holder
or the Corporation, into one share of Common Stock (a “Mandatory Conversion”). For purposes of
this Section 5, “Non-GE Holder” means any Person that is not (x) General Electric Capital
Corporation (“GECC”) or (y) any Person whose equity interests in the Corporation must be aggregated
with those of GECC for purposes of the Bank Holding Company Act of 1956, as amended, and the rules
and regulations promulgated thereunder, as in effect from time to time, and any other applicable
Federal banking law, regulation or policy.

5.2 Concurrently with, and as a condition to, any transfer of any shares of Series A
Preferred Stock to any Non-GE Holder (each such transfer, a “Qualified Transfer”), the transferor
and transferee of any shares of Series A Preferred Stock in such Qualified Transfer shall provide
the Corporation a written notice of such Qualified Transfer (a “Notice of Conversion”). Such
Notice of Conversion shall include: (a) a representation of such transferor that the transfer of
such shares of Series A Preferred Stock is a Qualified Transfer; (b) the name in which shares of
Common Stock to be issued upon such Mandatory Conversion should be registered; and (c) the manner
in which certificates of Series A Preferred Stock held by such holder are to be surrendered for
issuance of certificates representing shares of Common Stock. No later than twenty (20) business
days following delivery of the Notice of Conversion, with respect to any shares of Series A
Preferred Stock as to which a Mandatory Conversion shall have occurred, the Corporation shall issue
and deliver certificates representing shares of Common Stock to the holder thereof or such holder’s
designee upon presentation and surrender of the certificate evidencing such Series A Preferred
Stock to the Corporation and, if required, furnishing appropriate endorsements and transfer
documents and the payment of all transfer and similar taxes, and, in the event that such conversion
is with respect to some, but not all, of the shares of Series A Preferred Stock represented by the
certificate surrendered, the Corporation shall issue and deliver a certificate or certificates
representing the number of shares of Series A Preferred Stock that were not converted to Common
Stock.

5.3 Shares of Series A Preferred Stock converted pursuant this Section 5 will resume
the status of authorized and unissued preferred stock, undesignated as to series and available for
future issuance, provided, that any shares of Series A Preferred Stock so converted shall not be
reissued as shares of Series A Preferred Stock. All shares of Common Stock delivered upon
conversion of Series A Preferred Stock shall be duly authorized, validly issued, fully paid and
non-assessable.

5.4 The Corporation shall at all times reserve and keep available out of its
authorized but unissued Common Stock, solely for the purpose of effecting conversions pursuant to
this Section 5, the full number of shares of Common Stock from time to time issuable upon the
conversion of all shares of Series A Preferred Stock then outstanding and entitled to convert and
shall take all such action and obtain all such permits or orders as may be necessary to enable the
Corporation lawfully to issue such shares upon any such conversion.

Section 6. Liquidation Rights. In the event of any voluntary or involuntary
liquidation, dissolution or winding up of the affairs of the Corporation, the holders of Series A
Preferred Stock shall be entitled to share equally, ratably and on a parity with the holders of
Common Stock, as though Common Stock and Series A Preferred Stock were one and the same class.

Section 7. Redemption Rights. Except as provided in Section 3, the Series A Preferred
Stock shall not be redeemable.

Section 8. Legend. Each certificate for shares of Series A Preferred Stock shall bear
a legend that substantially describes the terms of a Mandatory Conversion set forth in Section 5.

[SIGNATURE PAGE FOLLOWS]

2

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designation to be duly
executed in its name and on its behalf on this        day of September, 2012.

CIFC CORP.

By:       

Name: Robert C. Milton, III

Title: Secretary and General Counsel

3

ANNEX B

to

Warrant

FORM OF EXERCISE

(To be executed by the registered holder hereof)

The undersigned registered owner of this Warrant irrevocably exercises this Warrant for the
purchase of [      ] shares of [Common Stock][Preferred Stock] of CIFC Corp., and herewith
makes payment therefor, all on the terms and conditions specified in this Warrant, and, subject to
Section 12.02 of the Warrant, requests that (i) certificates and/or other instruments
covering such shares of [Common Stock][Preferred Stock] be issued in accordance with the
instructions given below and (ii) if such shares of [Common Stock][Preferred Stock] shall not
include all of the Warrant Shares to which the Holder is entitled under this Warrant, that a new
Warrant of like tenor and date for the unpurchased balance of Warrant Shares issuable hereunder be
delivered to the undersigned.

Dated:       

     

(Signature of Registered Holder)

Instructions for issuance and

registration of shares of [Common Stock][Preferred Stock]:

      

Name of Registered Holder

(please print)

Social Security or other Identifying

Number:      

Please deliver certificate to the following address:

      

Street

      

City, State and Zip Code

4

ANNEX C

to

Warrant

FORM OF ASSIGNMENT

(To be executed by the registered holder hereof)

FOR VALUE RECEIVED the undersigned registered owner of this Warrant hereby sells, assigns and
transfers unto the assignee named below all the rights of the undersigned under this Warrant with
respect to the number of Warrant Shares covered thereby set forth hereinbelow:

	 	 	 	 	 
	
 
	 	 	 	Number of Warrant Shares
	Name of Assignee

	 	Address
	 	

	 

	 	 
	 	

Dated:       

     

Signature of Registered Holder

     

Name of Registered Holder

(Please Print)

Witness:

      

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]